Velocity Financial Inc
For the period ended Dec 31, 2024. Filed Mar 12, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 12, 2025
Contents
Notes
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2024, 2023 and 2022
Note 1 — Organization and Description of Business
Velocity Financial, LLC (VF or the Company) was a Delaware limited liability company (LLC) formed on July 9, 2012, for the purpose of acquiring all membership units in Velocity Commercial Capital, LLC (VCC). On January 16, 2020, Velocity Financial, LLC converted from a Delaware limited liability company to a Delaware corporation and changed its name to Velocity Financial, Inc. Upon completion of the conversion, the Velocity Financial, LLC’s Class A equity units of 97,513,533 and Class D equity units of 60,193,989 were converted to 11,749,994 shares of Velocity Financial, Inc. common stock. On January 22, 2020, the Company completed its initial public offering of 7,250,000 shares of common stock at a price to the public of $13.00 per share. On January 28, 2020, the Company completed the sale of an additional 1,087,500 shares of its common stock, representing the full exercise of the underwriters’ option to purchase additional shares, at a public offering price of $13.00 per share. The Company’s stock trades on The New York Stock Exchange under the symbol “VEL”.
VCC, a California LLC formed on June 2, 2004, is a mortgage lender that originates and acquires small balance investor real estate loans, providing capital to the investor real estate loan market. The Company is licensed as a California Finance Lender and, as such, is required to maintain a minimum net worth of $250 thousand. The Company does not believe there is any potential risk of not being able to meet this regulatory requirement. The Company uses its equity capital and borrowed funds to originate and invest in investor real estate loans and seeks to generate income based on the difference between the yield on its investor real estate loan portfolio and the cost of its borrowings. The Company does not engage in any other significant line of business or offer any other products or services, nor does it originate or acquire investments outside of the United States of America.
The Company, through its wholly owned subsidiaries, is the sole beneficial owner of the Velocity Commercial Capital Loan Trusts, from the 2017-2 Trust through and including the 2024-6 Trust, all of which are New York common law trusts, with the exception of the VCC 2022-MC1 Trust, VCC 2023-1R Trust, and VCC 2023-RTL1 Trust which are Delaware statutory trusts. The Trusts are bankruptcy remote, variable interest entities (“VIEs”) formed for the purpose of providing secured borrowings to the Company and are consolidated with the accounts of the Company.
On December 28, 2021, the Company acquired an 80% ownership interest in Century Health & Housing Capital, LLC (“Century”). Century is a licensed Government National Mortgage Association (“Ginnie Mae” or “GNMA”) issuer/servicer that provides government-insured Federal Housing Administration (“FHA”) mortgage financing for multifamily housing, senior housing and long-term care/assisted living facilities. Century originates loans through its borrower-direct origination channel and services the loans through its in-house servicing platform, which enables the formation of long-term relationships with its clients and drives strong portfolio retention. Century is a consolidated subsidiary of the Company as of completion of the acquisition. In addition, as a servicer of Ginnie Mae loans, Century is required to maintain a minimum net worth, and Century is in compliance with this requirement as of December 31, 2024.
Note 2 — Basis of Presentation and Summary of Significant Accounting Policies
The consolidated financial statements of the Company have been prepared on the accrual basis of accounting and in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”).
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of consolidated income and expenses during the reporting period.
Principles of Consolidation
The principles of consolidation require management to determine and reassess the requirement to consolidate VIEs each reporting period, and therefore, the determination may change based on new facts and circumstances pertaining to each VIE. This could result in a material impact to the Company’s consolidated financial statements in subsequent reporting periods.
The Company consolidates the assets, liabilities, and remainder interests of the Trusts as management determined that VCC is the primary beneficiary of these entities. The Company’s ongoing asset management responsibilities provide the Company with the power to direct the activities that most significantly impact the VIE’s economic performance, and the remainder interests provide the Company with the right to receive benefits and the obligation to absorb losses, limited to its investment in the remainder interest of the Trusts.
The consolidated financial statements as of December 31, 2024 and 2023, include only those assets, liabilities, and results of operations related to the business of the Company, its subsidiaries, and VIEs.
Business Combination
The Company accounts for its business combinations using the acquisition method of accounting. Assets acquired and the liabilities assumed as part of a business combination are recognized separately from goodwill at their acquisition date fair values. Goodwill is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. The Company, with the assistance of outside specialists as necessary, use estimates and assumptions to value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable. The Company may refine these estimates during the measurement period which may be up to one year from the acquisition date. As a result, during the measurement period, the Company records adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Consolidated Statements of Income.
Restricted Cash
Restricted cash consisted of the required specified reserves by the 2022-MC1 Trust agreement to pay the note on each payment date if collections on mortgage loans are insufficient to make payment on the note, funds in the 2023-RTL 1 Trust escrow account, and cash held by the Company for potential future advances due certain borrowers.
Loans Held for Investment and Loans Held for Sale
Except for loans originated in accordance with the guidelines of Ginnie Mae’s program, which loans are originated with the intent to sell, originated loans, and purchased loans are classified as held-for-investment when management has the intent and ability to hold such loans for the foreseeable future or until maturity. Loans held for investment originated prior to October 1, 2022, are carried at amortized cost, which is the outstanding principal balance, adjusted for net deferred loan origination costs and fees and allowance for credit losses. Loans originated or acquired after September 30, 2022, are carried at fair value.
Interest income is accrued on the unpaid principal balance (UPB) at their respective stated interest rates. Generally, loans are placed on nonaccrual status when they become 90 days past due. Loans are considered past due when contractually required principal or interest payments have not been made on the due dates. When a loan is placed on nonaccrual status, the accrued and unpaid interest is reversed as a reduction of interest income and accrued interest receivable. Interest income is subsequently recognized only to the extent cash payment is received on a nonaccrual loan provided the collection of the remaining recorded investment in the loan is deemed to be fully collectible or when the loan has been placed back in accrual status. Loans are restored to accrual status when: (1) the loan becomes current and none of its principal and interest is due and unpaid, and the Company expects repayment of the remaining contractual principal and interest, or (2) if the loan has been formally modified in a manner that reasonably assures repayment and performance according to its modified terms. Under these terms, the Company requires that the borrower continues to make the full modified principal and interest payments for six consecutive months before restoring the loan to accrual status.
The deferred loans under the Company’s forbearance program are considered current at the time of deferral, and the Company continues to accrue interest on these loans. Deferred loans that subsequently went 90 days past due after the deferral date were placed on nonaccrual status with any accrued interest income reversed through earnings.
For originated loans prior to October 1, 2022, carried at amortized cost, net deferred loan origination costs are amortized to interest income using the level yield method. Loan origination fees and costs on loans originated or acquired after September 30, 2022, are expensed as incurred.
Loans are classified as held for sale when management has the intent to sell them. Loans held for sale originated prior to October 1, 2022, are carried at lower of cost or estimated fair value. Loans held for sale originated or acquired effective October 1, 2022, are carried at estimated fair value. The Century loans are considered as held for sale until they meet the sale criteria described in the following paragraphs, which is generally when they are delivered to GNMA in exchange for GNMA securities. Century will continue to service the loans for Ginnie Mae.
On occasion, as part of the Company’s management strategy of the loans held in its portfolio, the Company will transfer loans from held for investment to held for sale. Upon transfer of any loans that were held at amortized cost, any associated allowance for credit loss is charged off and the carrying value of the loan is adjusted to the lower of cost or estimated fair value. The net deferred fees and costs associated with loans held for sale are deferred (not accreted or amortized to interest income) until the related loans are sold.
The Company recognizes transfers of loans as sales when it surrenders control over the loans. Control over transferred loans is deemed to be surrendered when: (1) the loans have been isolated from the Company, (2) the transferee has the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred loans, and (3) the Company does not maintain effective control over the transferred loans through either: (a) an agreement that entitles and obligates the Company to repurchase or redeem them before their maturity, or (b) the ability to unilaterally cause the holder to return the specific loans. Gains or losses on the sale of these loans are included in “Gain on disposition of loans” in the Consolidated Statements of Income.
Interest income on loans held for sale is recognized over the life of the loans using their contractual interest rates. Income recognition is suspended, and the unpaid interest receivable is reversed against interest income when loans become 90 days delinquent, or when, in management’s opinion, a full recovery of interest and principal becomes doubtful. Income recognition is resumed when the loan becomes contractually current.
Mortgage Servicing Rights
The Company retains the servicing rights of the Ginnie Mae insured loans that are sold in the secondary market by Century. Servicing rights are initially recorded at fair value with the income statement effect recorded in gain on disposition of loans.
Under the fair value measurement method, the Company measures servicing rights at fair value at each reporting date and reports changes in fair value of servicing assets in earnings in the period in which the changes occur and are included as a component of “Other operating income” on the Consolidated Statements of Income. The fair value of servicing rights is subject to significant fluctuations as a result of changes in estimated and actual prepayment speeds and default rates and losses. Loans serviced for others are not included in the Consolidated Balance Sheets.
Servicing fee income is recorded for fees earned for servicing loans. The fees are based on a contractual percentage of the outstanding principal or a fixed amount per loan and are recorded as income when earned.
Effective January 1, 2020, the Company adopted ASU 2016-13 Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments replacing the incurred loss accounting approach with the current expected credit loss approach for all financial assets measured at amortized cost, which as of the adoption date consisted entirely of its held for investment loan portfolio. Under the current expected credit loss (“CECL”) methodology, the allowance for credit losses is measured using two components. A component that measures expected credit losses on a collective (pool) basis when similar risk characteristics exist and a component that measures expected credit losses on an individual loan basis. For the collective pool component, the Company identified the following portfolio segments based on risk characteristics of the loans in its loan portfolio (pool):
Residential 1– 4 Unit – Purchase (loans to purchase 1– 4 unit residential rental properties);
Residential 1– 4 Unit – Refinance (refinance loans on 1– 4 unit residential rental properties);
Commercial – Purchase (loans to purchase traditional commercial properties);
Commercial – Refinance (refinance loans on traditional commercial properties);
Short Term 1– 4 Unit – Purchase (short-term loans to purchase 1– 4 unit residential rental properties); and
Short Term 1– 4 Unit – Refinance (short-term refinance loans on 1– 4 unit residential rental properties).
The Company determines the collectability of its loans in the collective pools by evaluating certain risk characteristics. The segmentation of its loan portfolio was determined based on analyses of its loan portfolio performance over the past ten years. Based on analyses of the loan portfolio’s historical performance, the Company concluded that loan purpose and product types are the most significant risk factors in determining its expectation of future credit losses. Loan purpose considers whether a borrower is acquiring the property or refinancing an existing property. The historical experience shows that refinance loans have higher loss rates than loans for property acquisitions. Product type includes residential 1-4 unit property and traditional commercial property. The historical experience shows that traditional commercial property loans have higher loss rates than residential 1-4 unit property loans. Short term loans have a maturity ofone totwo years from origination. Long term loans have a maturity of up to 30 years from origination.
The Company estimates the allowance for credit losses using relevant available information, from internal and external sources, relating to historical performance, current conditions, and reasonable and supportable macroeconomic forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. Adjustments to historical loss information are considered for differences in current loan-specific risk characteristics such as differences in underwriting standards, portfolio mix, delinquency levels, or term, as well as for changes in environmental conditions, such as unemployment rates, property values and changes in the competitive or regulatory environment.
The Company uses an open pool loss rate methodology to model expected credit losses. To determine the loss rates for the open pool method, the Company starts with its historical database of losses, segmenting the loans by loan purpose, product type and repayment period. A third-party model applying the open pool method is used to estimate annual average loss rates by dividing the respective pool’s quarterly historical losses by the pool’s respective prior quarter’s ending unamortized loan cost balance and deriving an annual average loss rate from the historical quarterly loss rates. The model then adjusts the annual average loss rates based upon macroeconomic forecasts over a reasonable and supportable period, followed by a straight-line reversion to the historical loss rates. The adjusted annual average loss rates are applied to the forecasted pool balance within each segment. The forecasted balances in the loan pool segments are calculated based on a principal amortization using contractual maturity, factoring in further principal reductions from estimated prepayments. Estimated prepayments, or Constant Prepayment Rates (“CPRs”) are developed from multiple loan characteristic considerations, such as property types, Fair Isaac Corporation (“FICO”) scores, loan purpose, and prepayment penalty terms, which is the most significant driver of prepayment activity. The prepayment penalty terms differ between the short-term and long-term loans, and the Company has developed a CPR curve for its short-term loans (two-year or less) and one for its long-term loans (30-year). Data from 2012-2024 is used to develop prepayment rates for the Company’s long-term loans. Because of the prepayment penalty structure in the Company’s long-term loans, prepayments during the active penalty term are historically low and begin to ramp up after the prepayment penalty term. The active prepayment penalty term is considered for existing and new loans over the reasonable and supportable forecast period in determining estimated prepayments. The Company back-tests the CPR curves on a quarterly basis and adjusts the CPR curves as appropriate. The reasonable and supportable period is meant to represent the period in which the Company believes the forecasted macroeconomic variables can be reasonably estimated. Significant variables or assumptions incorporated in the macroeconomic forecasts include U.S. unemployment, treasury yields, U.S. real gross domestic product (“GDP”), and U.S. real estate housing prices. The Company considers multiple scenarios from different macroeconomic forecasts and uses different forecast and reversion periods for estimating lifetime expected credit losses.
For the December 31, 2024 CECL estimate, the Company considered a severe stress scenario with a seven-quarter reasonable and supportable forecast period followed by a three-quarter straight-line reversion period. The severe stress scenario was applied to reflect the uncertainties of a decreasing forecasted GDP, unstable labor market, and geopolitical risk.
For the December 31, 2023 CECL estimate, the Company considered a severe stress scenario with an eight-quarter reasonable and supportable forecast period followed by a two-quarter straight-line reversion period. The severe stress scenario was applied due to the continued inflation in the United States, the geopolitical risk, continued disruption in the supply chain, and concerns of a recession.
For the December 31, 2022 CECL estimate, the Company considered a severe stress scenario with an eight-quarter reasonable and supportable forecast period followed by a two-quarter straight-line reversion period. The various scenarios, as well as the forecast period and reversion to historical loss is subject to change as conditions in the market change and the Company’s ability to forecast economic events evolves.
The Company has determined that once a loan becomes nonperforming (90 or more days past due), it no longer shares the same risk characteristics of the other loans within its segment of homogeneous loans (pool). The Company pulls these loans out of the segments and evaluates the loans individually using the practical expedient to determine the credit exposure. Nonperforming loans are considered collateral dependent by the Company. Using the practical expedient, the fair value of the underlying collateral, less estimated selling costs, is compared to the carrying value of the loan in the determination of a credit loss. The allowance for credit losses for individually assessed or evaluated loans is the difference between the fair value of the collateral underlying the loans at the reporting date, adjusted for estimated selling costs, and the amortized cost basis.
The allowance for credit losses is a valuation account that is deducted from the loans’ amortized cost basis to present the net amount expected to be collected on the loans. Loans are charged-off against the allowance when the Company believes the uncollectibility of a loan balance is confirmed. Expected recoveries do not exceed the aggregate of amounts previously charged-off and expected to be charged-off.
The allowance for credit losses is maintained at a level deemed adequate by management to provide for expected losses in the portfolio at the balance sheet date. While management uses available information to estimate its required allowance for credit losses, future additions to the allowance for credit losses may be necessary based on changes in estimates resulting from economic and other conditions.
The Company has made the accounting policy election not to measure an allowance for credit losses for accrued interest receivables. When a loan is placed on nonaccrual status, the accrued and unpaid interest is reversed as a reduction of interest income and accrued interest receivable. Accrued interest receivable is excluded from the amortized cost of loans and it is presented as “Accrued interest receivable” in the Consolidated Balance Sheets.
Effective October 1, 2022, the Company elected to apply FVO accounting to its newly originated loans. Loans carried at fair value do not require a separate allowance for credit loss since any loan impairment will be reflected in the fair value of the loan. All loans originated or acquired prior to October 1, 2022, are carried at amortized cost and are subject to a CECL reserve.
Accrued Interest and Other Receivables
Accrued interest and other receivables represent accrued and uncollected interest on loans in accrual status; principal and interest payments received, but unremitted by the servicer; and receivables from borrowers for escrow and other advances, net of an allowance for uncollectible borrower advances.
Properties acquired through foreclosure, deed in lieu of foreclosure, or from third parties that meet all of the following criteria are classified as real estate owned: (1) management has the intent to sell the property, (2) the property is available for immediate sale in its present condition, or management intends on making necessary repairs to render the property saleable, subject only to terms that are usual and customary, and (3) it is unlikely that any significant changes to the plan will be made or that the plan will be withdrawn.
Real estate owned is initially recorded at the property’s estimated fair value, based on appraisals or broker price opinions obtained, less estimated costs to sell at the acquisition date, establishing a new cost basis. If the recorded loan balance at the time of transfer exceeds the estimated fair value of the property less estimated costs to sell, the charge is recorded to the allowance for credit losses. If the estimated fair value of the property less estimated costs to sell exceeds the recorded loan balance at the time of transfer, the write-up is first recorded as a recapture to the allowance for credit losses to the extent of any previous charge and then to gain on the REO. Any subsequent write-downs in the fair value of the REO after the transfer date are charged to “Real estate owned, net” in the Consolidated Statements of Income and recognized through a valuation allowance. Subsequent increases in the fair value of the REO less selling costs reduce the valuation allowance, but not below zero, and are credited to “Real estate owned, net”.
Property and Equipment, Net
Property and equipment is recorded at cost, less accumulated depreciation, computed principally by the straight-line method based on the estimated useful lives of the specific assets, which range from three toseven years. Software is amortized over the estimated useful lives of the specific assets, which range from three toten years using the straight-line method. Leasehold improvements are amortized over the lives of the respective leases or the service lives of the improvements, whichever is shorter.
Goodwill
Goodwill arises from business combinations and is generally determined as the excess of the fair value of the consideration transferred over the fair value of the net assets acquired and liabilities assumed as of the acquisition date less any noncontrolling interest. Goodwill acquired in a purchase business combination and determined to have an indefinite useful life is not amortized but tested for impairment at least annually, or more frequently if events and circumstances exist that indicate that a goodwill impairment test should be performed.
Off Balance Sheet Credit Exposure
The Company hasno off-balance-sheet assets or liabilities with credit exposure.
Income taxes are accounted for using the asset and liability method. Under this method, a deferred tax asset or liability is measured based on the enacted tax rates expected to apply to taxable income in the years in which the differences between the financial statement carrying amounts and tax bases of existing assets and liabilities are expected to be recovered or settled. The effect on deferred taxes of a change in tax rates is recognized in income in the period that includes the enactment date.
Valuation allowances are established to reduce the net carrying amount of deferred tax assets (“DTA”) if it is determined to be more likely than not, that all or some portion of the potential deferred tax asset will not be realized.
In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the DTA will or will not be realized. The Company’s ultimate realization of the DTA is dependent upon the generation of future taxable income during the periods in which temporary differences become deductible. Management considers the nature and amount of historical and projected future taxable income, the scheduled reversal of deferred tax assets and liabilities, and available tax planning strategies in making this assessment. The amount of deferred taxes recognized could be impacted by changes to any of these variables.
The Company determines whether its tax positions are more likely than not to be sustained upon examination by the applicable taxing authorities, including resolution of any related appeals or litigation processes, based on the technical merits of the positions in question. Income tax positions that meet the more likely than not recognition threshold are measured to determine the amount of benefit to recognize. An income tax position is measured at the largest amount of benefit that management believes has a greater than 50% likelihood of realization upon settlement. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to unrecognized tax benefits in income tax expense.
Stock-Based Compensation
Compensation expense for stock options, and restricted stock awards is based on the fair value of the award at the date of grant. The fair value of stock options and options under the Company’s Employee Stock Purchase Plan (“ESPP”) is estimated at the date of grant using a Black-Scholes option pricing model. The fair value of restricted stock awards is determined based on the Company’s market price on the date of grant. Under the Company’s ESPP, employees may purchase shares of common stock at a price equal to 85% of the lesser of the fair market value of the stock on the first or the last trading day of each offering period. The Company records compensation expenses related to the discount given to participating employees. Compensation expense for performance stock units is measured using the fair value at the date of grant and recorded over each vesting period and may be adjusted over the vesting period based on interim estimates of performance against the pre-set objectives. Compensation expense for all stock-based awards is recognized in the consolidated financial statements on a straight-line basis over the requisite service period, which is generally defined as the vesting period. The Company recognizes forfeitures as they occur, and the income tax effects of awards are recognized in the Consolidated Statements of Income when awards vest or are settled.
Earnings per Share
Earnings per share are calculated utilizing the two-class method. Basic earnings per share are calculated by dividing the sum of distributed earnings to common shareholders and undistributed earnings allocated to common shareholders by the weighted average number of common shares outstanding. Diluted earnings per share are calculated by dividing the sum of distributed earnings to common shareholders and undistributed earnings allocated to common shareholders by the weighted average number of shares adjusted for the dilutive effect of stock-based awards.
Treasury shares
The Company separately presents treasury shares, which represent shares surrendered to the Company to satisfy tax withholding obligations in connection with the vesting or exercise of stock-based awards. Treasury shares are carried at cost.
Fair Value Option Accounting
The Company has elected to apply fair value option (“FVO”) accounting to originated mortgage loans on a go-forward basis beginning October 1, 2022. The fair value option loans are presented as a separate line item in the Consolidated Balance Sheets. Interest income on FVO loans is recorded on an accrual basis in the Consolidated Statements of Income under the heading “Interest income”. Changes in the fair value of the loans are recorded as
“Unrealized gain on fair value of loans” in the Consolidated Statements of Income. The Company does not record a CECL reserve on fair value option loans.
The Company has elected to apply FVO accounting to securitized debt issued effective January 1, 2023, when the underlying collateral is also carried at fair value. The FVO securitized debt is presented as a separate line item in the Consolidated Balance Sheets. The Company reflects interest expense on the fair value option securitized debt as “Interest expense - portfolio related” in the Consolidated Statements of Income and presents the other fair value changes of the FVO securitized debt separately in the Consolidated Statements of Income.
Derivative Instruments and Hedge Accounting
The Company issues fixed rate debt at regular intervals during the year through the securitization of its fixed rate mortgage assets. The Company is subject to interest rate risk on its forecasted debt issuances as these fixed rate debt issuances are priced at then-current market rates. The Company’s risk management objective is to hedge the risk of variability in its interest payment cash flows attributable to changes in the benchmark Secured Overnight Financing Rate (“SOFR”) between the time the fixed rate mortgages are originated and the fixed rate debt is issued. To accomplish this hedging strategy, the Company may from time to time enter into derivative instruments such as forward starting payer interest rate swaps or interest rate payer swaptions, and interest rate payer and receiver swaptions or swaption collar, designated as cash flow hedges that are designed to be highly correlated to the underlying terms of the forecasted debt instruments. To qualify for hedge accounting, the Company formally documents its hedging relationships at inception, including the identification of the hedging instruments and the hedged items, as well as its risk management objectives and strategies for undertaking the hedge transaction at the time the derivative contract is executed. The Company also formally assesses effectiveness both at the hedge’s inception and on an ongoing basis.
The Company’s policy is to present all derivative balances on a gross basis, without regard to counterparty master netting agreements or similar arrangements. The fair value of the derivative instruments is recorded as a separate line item on the Consolidated Balance Sheets as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive income (“AOCI”). Beginning in the period in which the forecasted debt issuance occurs and the related derivative instruments are terminated, the gains or losses accumulated in AOCI are then reclassified into interest expense as a yield adjustment over the term of the related debt. If the Company determines it is not probable that the forecasted transaction will occur, gains and losses are reclassified immediately to earnings. The related cash flows are recognized on the cash flows from operating activities section on the consolidated statements of cash flows. The Company uses hedge accounting based on the exposure being hedged as cash flow hedges in operations.
Other Comprehensive Income
Other comprehensive income (“OCI”) is reported in the consolidated statements of comprehensive income. OCI is comprised of net income and the effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges, net of tax, less amounts reclassified into earnings.
Accumulated other comprehensive income represents the cumulative balance of OCI, net of tax, as of the end of the reporting period and relates to unrealized gains or losses on cash flow hedges, net of tax.
Note 3 — Current Accounting Developments
Recently Issued Accounting Standards
Debt with Conversion and Other Options
In November 2024, the FASB issued ASU 2024-04, “Debt - Debt With Conversion and Other Options (Subtopic 220-40)”, which clarifies requirements for determining whether certain settlements of convertible debt instruments, including convertible debt instruments with cash conversion features or convertible debt instruments that are not currently convertible, should be accounted for as an induced conversion rather than as debt extinguishments. The accounting update is effective January 1, 2026 for the Company. The adoption of this standard is not expected to have a significant impact on the Company’s consolidated financial statements.
Expense Disaggregation
In November 2024, the FASB issued ASU 2024-03, “Income Statement - Reporting Comprehensive Income (Subtopic 220-40) Expense Disaggregation Disclosures”, which requires specific information about certain costs and expenses at each interim and annual reporting period. This includes disclosing amounts related to employee compensation, depreciation, and intangible asset amortization. In addition, qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively will need to be disclosed. The accounting update is effective January 1, 2027 for the Company. The adoption of this standard is not expected to have a significant impact on the Company’s consolidated financial statements.
Codification Improvements
In March 2024, the FASB issued ASU 2024-02, “Codification Improvements—Amendments to Remove References to the Concepts Statements,” which amends the Codification to remove references to various concepts statements and impacts a variety of topics in the Codification. The amendments apply to all reporting entities within the scope of the affected accounting guidance, but in most instances the references removed are extraneous and not required to understand or apply the guidance. Generally, the amendments in ASU 2024-02 are not intended to result in significant accounting changes for most entities. The accounting update is effective January 1, 2025 for the Company. The adoption of this standard is not expected to have a significant impact on the Company’s consolidated financial statements.
Compensation
In March 2024, the FASB issued ASU 2024-01, “Compensation— Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards,” clarifies how an entity determines whether a profits interest or similar award is (1) within the scope of ASC 718 - Compensation - Stock Compensation or (2) not a share-based payment arrangement and therefore within the scope of other guidance. The guidance in ASU 2024-01 applies to all entities that issue profits interest awards as compensation to employees or non-employees in exchange for goods or services. The adoption of this standard is not expected to have a significant impact on the Company’s consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 240): Improvements to Income Tax Disclosures,” which requires additional disclosure and disaggregated information in the Income Tax Rate reconciliation using both percentages and reporting currency amounts, with additional qualitative explanations of individually significant reconciling items. The updated guidance also requires disclosure of the amount of income taxes paid (net of refunds received) disaggregated by jurisdictional categories (federal (national), state, and foreign). The accounting update is effective January 1, 2025 for the Company. The adoption of this standard is not expected to have a significant impact on the Company’s consolidated financial statements.
Recently Adopted Accounting Standard
Segment Reporting
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted this guidance as of January 1, 2024, and the adoption did not have a material impact on its consolidated financial statements. See Note 29 - Segment Information for related disclosures.
Note 4 — Cash, Cash Equivalents, and Restricted Cash
The Company is required to hold cash for certain Trusts and potential future advances due certain borrowers. In accordance with various mortgage servicing and related agreements, Century maintains escrow accounts for mortgage insurance premium, tax and insurance, working capital, sinking fund and other mortgage related escrows. The total escrow balances payable amounted to$83.5 million and$79.7 million as of December 31, 2024 and 2023, respectively. These amounts are not reflected on the Consolidated Balance Sheets of the Company.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Company’s consolidated balance sheets that sum to the total of the same such amounts shown in the Consolidated Statements of Cash Flows as of December 31,2024, 2023 and 2022:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Cash and cash equivalents | $49,901 | $40,566 | $45,248 |
| Restricted cash | 20,929 | 21,361 | 16,808 |
| Total cash, cash equivalents, and restricted cash shown in the Consolidated Statements of Cash Flows | $70,830 | $61,927 | $62,056 |
Note 5 — Loans Held for Sale at Fair Value
The following table summarizes loans held for sale at fair value as of December 31, 2024 and 2023:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In thousands) | ||
| Unpaid principal balance | $— | $16,954 |
| Valuation adjustments on FVO loans held for sale | — | 636 |
| Ending balance | $— | $17,590 |
Note 6 — Loans Held for Investment at Amortized Cost and Loans Held for Investment at Fair Value
The following tables summarize loans held for investment as of December 31, 2024 and 2023:
| Loans Held for Investment at Amortized Cost | Loans Held for Investment at Fair Value | Total Loans Held for Investment | |
|---|---|---|---|
| (In thousands) | |||
| Unpaid principal balance | $2,400,720 | $2,655,217 | $5,055,937 |
| Valuation adjustments on FVO loans | — | 111,734 | 111,734 |
| Deferred loan origination costs | 23,570 | — | 23,570 |
| 2,424,290 | 2,766,951 | 5,191,241 | |
| Allowance for credit losses | (4,174) | — | (4,174) |
| Total loans held for investment | $2,420,116 | $2,766,951 | $5,187,067 |
| Loans Held for Investment at Amortized Cost | Loans Held for Investment at Fair Value | Total Loans Held for Investment | |
|---|---|---|---|
| (In thousands) | |||
| Unpaid principal balance | $2,804,541 | $1,251,395 | $4,055,936 |
| Valuation adjustments on FVO loans | — | 54,677 | 54,677 |
| Deferred loan origination costs | 28,351 | — | 28,351 |
| 2,832,892 | 1,306,072 | 4,138,964 | |
| Allowance for credit losses | (4,769) | — | (4,769) |
| Total loans held for investment | $2,828,123 | $1,306,072 | $4,134,195 |
During the years ended December 31, 2024, 2023 and 2022,$174.6 million,$201.0 million and$292.4 million, respectively, in UPB of loans held for investment have participated in the COVID-19 forbearance program and the Company granted a 90-days forbearance period on these loans. The following tables summarize the activity, UPB, and amortized cost basis of the loans in the Company’s COVID-19 forbearance program for the years ended December 31, 2024 and 2023:
| UPB | % | Amortized Cost | % | |
|---|---|---|---|---|
| ($ in thousands) | ||||
| Beginning balance | $174,571 | $176,515 | ||
| Foreclosures | (5,292) | (5,416) | ||
| Repayments | (26,452) | (26,852) | ||
| Ending balance | $142,827 | $144,247 | ||
| Performing/Accruing | $102,769 | 72.0% | $103,790 | 72.0% |
| Nonperforming/Nonaccrual | $40,058 | 28.0% | $40,457 | 28.0% |
| UPB | % | Amortized Cost | % | |
|---|---|---|---|---|
| ($ in thousands) | ||||
| Beginning balance | $201,005 | $203,346 | ||
| Foreclosures | (833) | (830) | ||
| Repayments | (25,601) | (26,001) | ||
| Ending balance | $174,571 | $176,515 | ||
| Performing/Accruing | $132,389 | 75.8% | $133,771 | 75.8% |
| Nonperforming/Nonaccrual | $42,182 | 24.2% | $42,744 | 24.2% |
Since April 1, 2020, the inception of the COVID-19 forbearance program, the Company has modified$412.9 million in UPB of loans, which includes capitalized interest of$14.8 million. As of December 31, 2024,$268.5 million in UPB of modified loans has been paid down, which includes$6.3 million of capitalized interest received.
Approximately 72.0% and 75.8% of the COVID forbearance loans in UPB were performing, and 28.0% and 24.2% were on nonaccrual status as of December 31, 2024 and 2023, respectively.
As of December 31, 2024 and 2023, the gross unpaid principal balance of loans held for investment pledged as collateral for the Company’s warehouse facility agreements, and securitized debt issued were as follows:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In thousands) | ||
| The 2013 repurchase agreement | $133,577 | $132,505 |
| The bank credit agreement | — | 39,619 |
| The 2021/2024 repurchase agreements | 148,676 | 103,787 |
| The 2021 term repurchase agreement | 74,324 | 41,628 |
| The July 2021 term repurchase agreement | — | 30,923 |
| The 2023 repurchase agreement | 42,613 | 29,501 |
| The 2024 bank credit agreement | 23,330 | — |
| Total pledged loans | $422,520 | $377,963 |
| 2017-2 Trust | $39,231 | $50,554 |
| 2018-1 Trust | 28,564 | 37,810 |
| 2018-2 Trust | 62,845 | 85,122 |
| 2019-1 Trust | 71,521 | 87,677 |
| 2019-2 Trust | 52,417 | 73,166 |
| 2019-3 Trust | 52,177 | 64,403 |
| 2020-1 Trust | 98,858 | 116,843 |
| 2020-2 Trust | — | 69,085 |
| 2021-1 Trust | 162,750 | 182,184 |
| 2021-2 Trust | 130,363 | 148,989 |
| 2021-3 Trust | 136,891 | 159,565 |
| 2021-4 Trust | 219,907 | 245,945 |
| 2022-1 Trust | 222,909 | 245,372 |
| 2022-2 Trust | 201,363 | 222,333 |
| 2022-MC1 Trust | 58,133 | 73,840 |
| 2022-3 Trust | 253,621 | 278,268 |
| 2022-4 Trust | 254,668 | 298,758 |
| 2022-5 Trust | 187,078 | 223,112 |
| 2023-1 Trust | 180,941 | 217,220 |
| 2023-2 Trust | 165,155 | 214,221 |
| 2023-3 Trust | 200,943 | 255,699 |
| 2023-RTL1 Trust | 85,530 | 79,465 |
| 2023-4 Trust | 185,013 | 227,940 |
| 2024-1 Trust | 188,638 | — |
| 2024-2 Trust | 271,542 | — |
| 2024-3 Trust | 198,640 | — |
| 2024-4 Trust | 248,788 | — |
| 2024-5 Trust | 293,881 | — |
| 2024-6 Trust | 299,216 | — |
| Total | $4,551,583 | $3,657,571 |
(a)
Nonaccrual Loans
The following tables present the amortized cost basis, or recorded investment, of the Company’s loans held for investment, excluding loans carried at fair value, that were nonperforming and on nonaccrual status as of December 31, 2024 and 2023.
| Total Nonaccrual | Nonaccrual with No Allowance for Credit Losses | Nonaccrual with Allowance for Credit Losses | Allowance for Loans Individually Evaluated | |
|---|---|---|---|---|
| (In thousands) | ||||
| Commercial - Purchase | $33,290 | $32,294 | $996 | $85 |
| Commercial - Refinance | 99,683 | 96,155 | 3,528 | 421 |
| Residential 1-4 Unit - Purchase | 29,573 | 29,573 | — | — |
| Residential 1-4 Unit - Refinance | 122,439 | 114,265 | 8,174 | 450 |
| Short Term 1-4 Unit - Purchase | 4,754 | 4,754 | — | — |
| Short Term 1-4 Unit - Refinance | 23,556 | 23,341 | 215 | 73 |
| Total | $313,295 | $300,382 | $12,913 | $1,029 |
| Total Nonaccrual | Nonaccrual with No Allowance for Credit Losses | Nonaccrual with Allowance for Credit Losses | Allowance for Loans Individually Evaluated | |
|---|---|---|---|---|
| (In thousands) | ||||
| Commercial - Purchase | $28,221 | $27,037 | $1,184 | $156 |
| Commercial - Refinance | 86,890 | 84,575 | 2,315 | 444 |
| Residential 1-4 Unit - Purchase | 36,253 | 36,253 | — | — |
| Residential 1-4 Unit - Refinance | 137,925 | 134,579 | 3,346 | 245 |
| Short Term 1-4 Unit - Purchase | 6,402 | 6,402 | — | — |
| Short Term 1-4 Unit - Refinance | 29,663 | 27,059 | 2,604 | 129 |
| Total | $325,354 | $315,905 | $9,449 | $974 |
The Company has made the accounting policy election not to measure an allowance for credit losses for accrued interest receivables. The Company has also made the accounting policy election to write off accrued interest receivables by reversing interest income when loans are placed on nonaccrual status, or 90 days or more past due. Any future payments received for these loans will be recognized on a cash basis.
The following table presents the amortized cost basis in the loans held for investment as of December 31, 2024 and 2023, and the amount of accrued interest receivable written off by reversing interest income by portfolio segment loans that have been placed on nonaccrual for the years ended December 31, 2024 and 2023:
| December 31, | ||||
|---|---|---|---|---|
| 2024 | 2023 | |||
| Amortized Cost | Interest Reversal | Amortized Cost | Interest Reversal | |
| (In thousands) | ||||
| Commercial - Purchase | $565,815 | $757 | $631,925 | $788 |
| Commercial - Refinance | 714,970 | 1,601 | 799,816 | 2,084 |
| Residential 1-4 Unit - Purchase | 420,107 | 783 | 511,080 | 1,239 |
| Residential 1-4 Unit - Refinance | 668,869 | 1,736 | 808,149 | 2,918 |
| Short Term 1-4 Unit - Purchase | 30,816 | 253 | 41,111 | 174 |
| Short Term 1-4 Unit - Refinance | 23,713 | 203 | 40,811 | 459 |
| Total | $2,424,290 | $5,333 | $2,832,892 | $7,662 |
For the years ended December 31, 2024 and 2023, cash basis interest income recognized on nonaccrual loans, including loans carried at fair value, was$36.7 million and$30.6 million, respectively. No accrued interest income was recognized on nonaccrual loans for the years ended December 31, 2024 and 2023. The average recorded investment of individually evaluated loans, computed using month-end balances, was$322.2 million and$331.4 million for the years ended December 31, 2024 and 2023, respectively. There were no commitments to lend additional funds to debtors whose loans have been modified as of December 31, 2024 and 2023.
(b)
The following tables present the activity in the allowance for credit losses for the years ended December 31, 2024 and 2023:
| Commercial Purchase | Commercial Refinance | Residential 1-4 Unit Purchase | Residential 1-4 Unit Refinance | Short Term 1-4 Unit Purchase | Short Term 1-4 Unit Refinance | Total | |
|---|---|---|---|---|---|---|---|
| (In thousands) | |||||||
| Allowance for credit losses: | |||||||
| Balance - January 1, 2024 | $935 | $1,805 | $585 | $1,256 | $23 | $165 | $4,769 |
| Provision for (reversal of) credit losses | (212) | (342) | 800 | 386 | 140 | 401 | 1,173 |
| Charge-offs | (61) | (64) | (639) | (361) | (151) | (492) | (1,768) |
| Ending balance | $662 | $1,399 | $746 | $1,281 | $12 | $74 | $4,174 |
| Allowance related to: | |||||||
| Loans individually evaluated | $85 | $421 | $— | $450 | $— | $73 | $1,029 |
| Loans collectively evaluated | $577 | $978 | $746 | $831 | $12 | $1 | $3,145 |
| Amortized cost related to: | |||||||
| Loans individually evaluated | $33,290 | $99,683 | $29,573 | $122,439 | $4,754 | $23,556 | $313,295 |
| Loans collectively evaluated | $532,525 | $615,287 | $390,534 | $546,430 | $26,062 | $157 | $2,110,995 |
| Commercial Purchase | Commercial Refinance | Residential 1-4 Unit Purchase | Residential 1-4 Unit Refinance | Short Term 1-4 Unit Purchase | Short Term 1-4 Unit Refinance | Total | |
|---|---|---|---|---|---|---|---|
| (In thousands) | |||||||
| Allowance for credit losses: | |||||||
| Balance - January 1, 2023 | $639 | $2,031 | $542 | $1,272 | $21 | $388 | $4,893 |
| Provision for (reversal of) credit losses | 296 | 6 | 180 | (5) | 388 | 1,050 | 1,915 |
| Charge-offs | — | (232) | (137) | (11) | (386) | (1,273) | (2,039) |
| Ending balance | $935 | $1,805 | $585 | $1,256 | $23 | $165 | $4,769 |
| Allowance related to: | |||||||
| Loans individually evaluated | $156 | $444 | $— | $245 | $— | $129 | $974 |
| Loans collectively evaluated | $779 | $1,361 | $585 | $1,011 | $23 | $36 | $3,795 |
| Amortized cost related to: | |||||||
| Loans individually evaluated | $28,221 | $86,890 | $36,253 | $137,925 | $6,402 | $29,663 | $325,354 |
| Loans collectively evaluated | $603,704 | $712,926 | $474,827 | $670,224 | $34,709 | $11,148 | $2,507,538 |
(c)
Credit Quality Indicator
A credit quality indicator is a statistic used by the Company to monitor and assess the credit quality of loans held for investment, excluding loans held for investment at fair value. The Company monitors its charge-off rate in relation to its nonperforming loans as its credit quality indicator. The rates of charge-offs over the average nonperforming loans were 0.55%,0.62% and 0.20% for the years ended December 31, 2024, 2023 and 2022, respectively.
Other credit quality indicators include aging status and accrual status. Nonperforming loans are loans that are 90 or more days past due, in bankruptcy, in foreclosure, or not accruing interest. The following tables present the aging status of the amortized cost basis in the loans held for investment portfolio, which include$144.2 million and$176.5 million loans in the Company’s COVID-19 forbearance program as of December 31, 2024 and 2023, respectively:
| December 31, 2024 | 30–59 Days Past Due | 60–89 Days Past Due | 90+ Days Past Due(1) | Total Past Due | Current | Total Loans |
|---|---|---|---|---|---|---|
| (In thousands) | ||||||
| Loans individually evaluated: | ||||||
| Commercial - Purchase | $387 | $555 | $32,348 | $33,290 | $— | $33,290 |
| Commercial - Refinance | 3,903 | 3,326 | 92,454 | 99,683 | — | 99,683 |
| Residential 1-4 Unit - Purchase | 606 | 957 | 28,010 | 29,573 | — | 29,573 |
| Residential 1-4 Unit - Refinance | 4,784 | 708 | 116,947 | 122,439 | — | 122,439 |
| Short Term 1-4 Unit - Purchase | — | — | 4,754 | 4,754 | — | 4,754 |
| Short Term 1-4 Unit - Refinance | — | 203 | 23,353 | 23,556 | — | 23,556 |
| Total loans individually evaluated | $9,680 | $5,749 | $297,866 | $313,295 | $— | $313,295 |
| Loans collectively evaluated: | ||||||
| Commercial - Purchase | $19,633 | $12,027 | $— | $31,660 | $500,865 | $532,525 |
| Commercial - Refinance | 37,480 | 12,132 | — | 49,612 | 565,675 | 615,287 |
| Residential 1-4 Unit - Purchase | 16,040 | 7,479 | — | 23,519 | 367,015 | 390,534 |
| Residential 1-4 Unit - Refinance | 32,398 | 14,302 | — | 46,700 | 499,730 | 546,430 |
| Short Term 1-4 Unit - Purchase | 10,073 | — | — | 10,073 | 15,989 | 26,062 |
| Short Term 1-4 Unit - Refinance | — | — | — | — | 157 | 157 |
| Total loans collectively evaluated | $115,624 | $45,940 | $— | $161,564 | $1,949,431 | $2,110,995 |
| Ending balance | $125,304 | $51,689 | $297,866 | $474,859 | $1,949,431 | $2,424,290 |
(1)
| December 31, 2023 | 30–59 Days Past Due | 60–89 Days Past Due | 90+ Days Past Due(1) | Total Past Due | Current | Total Loans |
|---|---|---|---|---|---|---|
| (In thousands) | ||||||
| Loans individually evaluated: | ||||||
| Commercial - Purchase | $2,329 | $668 | $25,224 | $28,221 | $— | $28,221 |
| Commercial - Refinance | 4,716 | 2,405 | 79,769 | 86,890 | — | 86,890 |
| Residential 1-4 Unit - Purchase | 544 | — | 35,709 | 36,253 | — | 36,253 |
| Residential 1-4 Unit - Refinance | 2,988 | 1,923 | 133,014 | 137,925 | — | 137,925 |
| Short Term 1-4 Unit - Purchase | — | — | 6,402 | 6,402 | — | 6,402 |
| Short Term 1-4 Unit - Refinance | 55 | — | 29,608 | 29,663 | — | 29,663 |
| Total loans individually evaluated | $10,632 | $4,996 | $309,726 | $325,354 | $— | $325,354 |
| Loans collectively evaluated: | ||||||
| Commercial - Purchase | $21,342 | $8,352 | $— | $29,694 | $574,010 | $603,704 |
| Commercial - Refinance | 47,430 | 14,002 | — | 61,432 | 651,494 | 712,926 |
| Residential 1-4 Unit - Purchase | 29,236 | 6,850 | — | 36,086 | 438,741 | 474,827 |
| Residential 1-4 Unit - Refinance | 52,510 | 20,828 | — | 73,338 | 596,886 | 670,224 |
| Short Term 1-4 Unit - Purchase | 1,169 | 658 | — | 1,827 | 32,882 | 34,709 |
| Short Term 1-4 Unit - Refinance | 2,978 | 213 | — | 3,191 | 7,957 | 11,148 |
| Total loans collectively evaluated | $154,665 | $50,903 | $— | $205,568 | $2,301,970 | $2,507,538 |
| Ending balance | $165,297 | $55,899 | $309,726 | $530,922 | $2,301,970 | $2,832,892 |
(1)
The following table presents the aging of the amortized cost basis of loans held for investment in the Company’s COVID-19 forbearance program as of December 31, 2024 and 2023:
| December 31, 2024 | 30–59 Days Past Due | 60–89 Days Past Due | 90+ Days Past Due(1) | Total Past Due | Current | Total Loans |
|---|---|---|---|---|---|---|
| (In thousands) | ||||||
| Loans individually evaluated: | ||||||
| Commercial - Purchase | $230 | $162 | $4,496 | $4,888 | $— | $4,888 |
| Commercial - Refinance | 242 | 1,491 | 17,749 | 19,482 | — | 19,482 |
| Residential 1-4 Unit - Purchase | 607 | — | 1,124 | 1,731 | — | 1,731 |
| Residential 1-4 Unit - Refinance | 90 | — | 6,066 | 6,156 | — | 6,156 |
| Short Term 1-4 Unit - Purchase | — | — | — | — | — | — |
| Short Term 1-4 Unit - Refinance | — | — | 8,200 | 8,200 | — | 8,200 |
| Total loans individually evaluated | $1,169 | $1,653 | $37,635 | $40,457 | $— | $40,457 |
| Loans collectively evaluated: | ||||||
| Commercial - Purchase | $1,768 | $— | $— | $1,768 | $12,546 | $14,314 |
| Commercial - Refinance | 6,169 | 412 | — | 6,581 | 35,322 | 41,903 |
| Residential 1-4 Unit - Purchase | 793 | — | — | 793 | 4,503 | 5,296 |
| Residential 1-4 Unit - Refinance | 1,708 | 458 | — | 2,166 | 16,093 | 18,259 |
| Short Term 1-4 Unit - Purchase | 9,154 | — | — | 9,154 | 14,864 | 24,018 |
| Short Term 1-4 Unit - Refinance | — | — | — | — | — | — |
| Total loans collectively evaluated | $19,592 | $870 | $— | $20,462 | $83,328 | $103,790 |
| Ending balance | $20,761 | $2,523 | $37,635 | $60,919 | $83,328 | $144,247 |
(1)
| December 31, 2023 | 30–59 Days Past Due | 60–89 Days Past Due | 90+ Days Past Due(1) | Total Past Due | Current | Total Loans |
|---|---|---|---|---|---|---|
| (In thousands) | ||||||
| Loans individually evaluated: | ||||||
| Commercial - Purchase | $— | $— | $2,803 | $2,803 | $— | $2,803 |
| Commercial - Refinance | 349 | — | 17,054 | 17,403 | — | 17,403 |
| Residential 1-4 Unit - Purchase | — | — | 523 | 523 | — | 523 |
| Residential 1-4 Unit - Refinance | 467 | 779 | 12,910 | 14,156 | — | 14,156 |
| Short Term 1-4 Unit - Purchase | — | — | — | — | — | — |
| Short Term 1-4 Unit - Refinance | — | — | 7,860 | 7,860 | — | 7,860 |
| Total loans individually evaluated | $816 | $779 | $41,150 | $42,745 | $— | $42,745 |
| Loans collectively evaluated: | ||||||
| Commercial - Purchase | $1,016 | $1,959 | $— | $2,975 | $16,608 | $19,583 |
| Commercial - Refinance | 8,102 | 1,433 | — | 9,535 | 47,257 | 56,792 |
| Residential 1-4 Unit - Purchase | 1,615 | 227 | — | 1,842 | 8,808 | 10,650 |
| Residential 1-4 Unit - Refinance | 1,423 | 789 | — | 2,212 | 21,462 | 23,674 |
| Short Term 1-4 Unit - Purchase | — | — | — | — | 23,071 | 23,071 |
| Short Term 1-4 Unit - Refinance | — | — | — | — | — | — |
| Total loans collectively evaluated | $12,156 | $4,408 | $— | $16,564 | $117,206 | $133,770 |
| Ending balance | $12,972 | $5,187 | $41,150 | $59,309 | $117,206 | $176,515 |
(1)
In addition to the aging status, the Company also evaluates credit quality by accrual status. The following tables present the amortized cost in loans held for investment, excluding loans held for investment at fair value, based on accrual status and by loan origination year as of December 31, 2024 and 2023.
| Term Loans Amortized Cost Basis by Origination Year | ||||||
|---|---|---|---|---|---|---|
| December 31, 2024 | 2022 | 2021 | 2020 | 2019 | Prior | Total |
| (In thousands) | ||||||
| Commercial - Purchase | ||||||
| Payment performance | ||||||
| Performing | $223,564 | $210,742 | $24,253 | $33,505 | $40,461 | $532,525 |
| Nonperforming | 13,046 | 6,524 | 4,994 | 5,758 | 2,968 | 33,290 |
| Total Commercial - Purchase | $236,610 | $217,266 | $29,247 | $39,263 | $43,429 | $565,815 |
| Commercial - Refinance | ||||||
| Payment performance | ||||||
| Performing | $207,766 | $167,568 | $40,772 | $76,886 | $122,295 | $615,287 |
| Nonperforming | 26,624 | 19,172 | 4,305 | 18,708 | 30,874 | 99,683 |
| Total Commercial - Refinance | $234,390 | $186,740 | $45,077 | $95,594 | $153,169 | $714,970 |
| Residential 1-4 Unit - Purchase | ||||||
| Payment performance | ||||||
| Performing | $173,252 | $167,804 | $8,166 | $17,740 | $23,572 | $390,534 |
| Nonperforming | 9,724 | 12,384 | 1,704 | 657 | 5,104 | 29,573 |
| Total Residential 1-4 Unit - Purchase | $182,976 | $180,188 | $9,870 | $18,397 | $28,676 | $420,107 |
| Residential 1-4 Unit - Refinance | ||||||
| Payment performance | ||||||
| Performing | $226,187 | $201,247 | $16,116 | $46,487 | $56,393 | $546,430 |
| Nonperforming | 46,873 | 34,974 | 7,560 | 15,176 | 17,856 | 122,439 |
| Total Residential 1-4 Unit - Refinance | $273,060 | $236,221 | $23,676 | $61,663 | $74,249 | $668,869 |
| Short Term 1-4 Unit - Purchase | ||||||
| Payment performance | ||||||
| Performing | $2,044 | $— | $17,985 | $6,033 | $— | $26,062 |
| Nonperforming | 4,170 | — | 584 | — | — | 4,754 |
| Total Short Term 1-4 Unit - Purchase | $6,214 | $— | $18,569 | $6,033 | $— | $30,816 |
| Short Term 1-4 Unit - Refinance | ||||||
| Payment performance | ||||||
| Performing | $157 | $— | $— | $— | $— | $157 |
| Nonperforming | 8,293 | — | 2,186 | 9,042 | 4,035 | 23,556 |
| Total Short Term 1-4 Unit - Refinance | $8,450 | $— | $2,186 | $9,042 | $4,035 | $23,713 |
| Total Portfolio | $941,700 | $820,415 | $128,625 | $229,992 | $303,558 | $2,424,290 |
| Gross charge-offs - quarter-ended December 31, 2024 | $111 | $184 | $— | $265 | $139 | $699 |
| Gross charge-offs - year-ended December 31, 2024 | $1,132 | $219 | $— | $265 | $152 | $1,768 |
| Term Loans Amortized Cost Basis by Origination Year | ||||||
|---|---|---|---|---|---|---|
| December 31, 2023 | 2022 | 2021 | 2020 | 2019 | Prior | Total |
| (In thousands) | ||||||
| Commercial - Purchase | ||||||
| Payment performance | ||||||
| Performing | $248,153 | $226,467 | $31,692 | $43,829 | $53,563 | $603,704 |
| Nonperforming | 9,600 | 6,104 | 567 | 4,773 | 7,177 | 28,221 |
| Total Commercial - Purchase | $257,753 | $232,571 | $32,259 | $48,602 | $60,740 | $631,925 |
| Commercial - Refinance | ||||||
| Payment performance | ||||||
| Performing | $233,052 | $188,723 | $47,883 | $92,819 | $150,449 | $712,926 |
| Nonperforming | 20,462 | 14,168 | 4,207 | 14,167 | 33,886 | 86,890 |
| Total Commercial - Refinance | $253,514 | $202,891 | $52,090 | $106,986 | $184,335 | $799,816 |
| Residential 1-4 Unit - Purchase | ||||||
| Payment performance | ||||||
| Performing | $208,456 | $198,110 | $9,581 | $24,429 | $34,251 | $474,827 |
| Nonperforming | 17,287 | 10,740 | 701 | 1,421 | 6,104 | 36,253 |
| Total Residential 1-4 Unit - Purchase | $225,743 | $208,850 | $10,282 | $25,850 | $40,355 | $511,080 |
| Residential 1-4 Unit - Refinance | ||||||
| Payment performance | ||||||
| Performing | $277,980 | $237,159 | $19,752 | $61,136 | $74,197 | $670,224 |
| Nonperforming | 43,272 | 36,344 | 7,835 | 28,252 | 22,222 | 137,925 |
| Total Residential 1-4 Unit - Refinance | $321,252 | $273,503 | $27,587 | $89,388 | $96,419 | $808,149 |
| Short Term 1-4 Unit - Purchase | ||||||
| Payment performance | ||||||
| Performing | $11,458 | $180 | $18,510 | $4,561 | $— | $34,709 |
| Nonperforming | 5,533 | 165 | 704 | — | — | 6,402 |
| Total Short Term 1-4 Unit - Purchase | $16,991 | $345 | $19,214 | $4,561 | $— | $41,111 |
| Short Term 1-4 Unit - Refinance | ||||||
| Payment performance | ||||||
| Performing | $11,148 | $— | $— | $— | $— | $11,148 |
| Nonperforming | 4,313 | 153 | 7,435 | 13,612 | 4,150 | 29,663 |
| Total Short Term 1-4 Unit - Refinance | $15,461 | $153 | $7,435 | $13,612 | $4,150 | $40,811 |
| Total Portfolio | $1,090,714 | $918,313 | $148,867 | $288,999 | $385,999 | $2,832,892 |
| Gross charge-offs - quarter-ended December 31, 2023 | $744 | $— | $— | $— | $— | $744 |
| Gross charge-offs - year-ended December 31, 2023 | $1,120 | $473 | $— | $446 | $— | $2,039 |
(d)
Nonaccrual Loans - Loans Held for Investment at Fair Value
The following table presents the aggregate fair value of loans held for investment at fair value that are 90 days or more past due and/or in nonaccrual status, and the difference between the aggregate fair value and the aggregate unpaid principal balance as of December 31, 2024 and 2023, by loan segments:
| Fair Value · Unpaid Principal Balance · Difference | |||||||
|---|---|---|---|---|---|---|---|
| Current–89 Days · 90+ Days Past Due · Current–89 Days · 90+ Days Past Due · 90+ Days Past Due | |||||||
| December 31, 2024 | Past Due | or Nonaccrual | Total | Past Due | or Nonaccrual | Total | or Nonaccrual |
| (In thousands) | |||||||
| Commercial - Purchase | $505,244 | $15,636 | $520,880 | $466,526 | $18,586 | $485,112 | $(2,950) |
| Commercial - Refinance | 672,504 | 24,129 | 696,633 | 620,332 | 29,195 | 649,527 | (5,066) |
| Residential 1-4 Unit - Purchase | 381,660 | 28,352 | 410,012 | 366,431 | 34,457 | 400,888 | (6,105) |
| Residential 1-4 Unit - Refinance | 862,971 | 103,985 | 966,956 | 819,633 | 126,340 | 945,973 | (22,355) |
| Short Term 1-4 Unit - Purchase | 78,863 | 3,981 | 82,844 | 78,207 | 4,854 | 83,061 | (873) |
| Short Term 1-4 Unit - Refinance | 76,277 | 13,349 | 89,626 | 74,620 | 16,036 | 90,656 | (2,687) |
| Ending balance | $2,577,519 | $189,432 | $2,766,951 | $2,425,749 | $229,468 | $2,655,217 | $(40,036) |
| Fair Value · Unpaid Principal Balance · Difference | |||||||
|---|---|---|---|---|---|---|---|
| Current–89 Days · 90+ Days Past Due · Current–89 Days · 90+ Days Past Due · 90+ Days Past Due | |||||||
| December 31, 2023 | Past Due | or Nonaccrual | Total | Past Due | or Nonaccrual | Total | or Nonaccrual |
| (In thousands) | |||||||
| Commercial - Purchase | $204,282 | $4,651 | $208,933 | $188,924 | $5,635 | $194,559 | $(984) |
| Commercial - Refinance | 230,034 | 7,399 | 237,433 | 210,716 | 8,962 | 219,678 | (1,563) |
| Residential 1-4 Unit - Purchase | 238,215 | 12,886 | 251,101 | 231,494 | 15,428 | 246,922 | (2,542) |
| Residential 1-4 Unit - Refinance | 472,615 | 29,335 | 501,950 | 448,780 | 35,119 | 483,899 | (5,784) |
| Short Term 1-4 Unit - Purchase | 46,312 | 1,769 | 48,081 | 45,695 | 2,143 | 47,838 | (374) |
| Short Term 1-4 Unit - Refinance | 54,041 | 4,533 | 58,574 | 53,008 | 5,491 | 58,499 | (958) |
| Ending balance | $1,245,499 | $60,573 | $1,306,072 | $1,178,617 | $72,778 | $1,251,395 | $(12,205) |
Note 7 — Mortgage Loans on Real Estate
The following tables present the Company’s loans (UPB) collateralized by real estate as of December 31, 2024 and 2023:
| Description | InterestRate | FinalMaturityDate | UnpaidPrincipalBalance(1)(2) | Nonaccrual UnpaidPrincipalBalance |
|---|---|---|---|---|
| ($ in thousands) | ||||
| 1-4 unit residential(3) | ||||
| Under $1.0 million | 4.0% - 15.0% | January 1, 2055 | $2,022,878 | $253,887 |
| $1.0 million and over | 4.0% - 13.2% | January 1, 2055 | 630,386 | 106,382 |
| 2,653,264 | 360,269 | |||
| Traditional commercial(4) | ||||
| Under $1.0 million | 4.0% - 14.0% | January 1, 2055 | 1,668,507 | 128,590 |
| $1.0 million and over | 4.0% - 13.3% | January 1, 2055 | 734,166 | 50,579 |
| 2,402,673 | 179,169 | |||
| Total at December 31, 2024 | $5,055,937 | $539,438 | ||
| Description | InterestRate | FinalMaturityDate | UnpaidPrincipalBalance(1)(2) | Nonaccrual UnpaidPrincipalBalance |
|---|---|---|---|---|
| ($ in thousands) | ||||
| 1-4 unit residential(3) | ||||
| Under $1.0 million | 4.0% - 15.0% | January 1, 2054 | $1,674,434 | $185,391 |
| $1.0 million and over | 4.0% - 13.2% | January 1, 2054 | 567,314 | 80,976 |
| 2,241,748 | 266,367 | |||
| Traditional commercial(4) | ||||
| Under $1.0 million | 4.0% - 14.0% | January 1, 2054 | 1,322,387 | 86,755 |
| $1.0 million and over | 4.0% - 13.3% | January 1, 2054 | 508,755 | 41,440 |
| 1,831,142 | 128,195 | |||
| Total at December 31, 2023 | $4,072,890 | $394,562 | ||
(1)
The aggregate cost of the Company’s loan portfolio for Federal income tax purposes were$5.2 billion and$4.2 billion as of December 31, 2024 and 2023, respectively.
(2)
As of December 31, 2024 and 2023,$228.3 million and$188.5 million, respectively, of the total UPB were interest-only loans with interest payable monthly and the principal payable at maturity.
(3)
The principal and interest on the 1-4 unit residential mortgage loans is payable monthly over the life of the loan to maturity. These loans generally contain a prepayment penalty provision if the loan is prepaid within the first 5 years.
(4)
The principal and interest on the traditional commercial mortgage loans is payable monthly over the life of the loan to maturity. These loans generally contain a prepayment penalty provision if the loan is prepaid within the first 5 years.
The following table presents the reconciliation of the UPB of mortgage loans for the years ended December 31, 2024, 2023 and 2022:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Balance at beginning of period | $4,072,890 | $3,512,486 | $2,587,220 |
| Addition during period: | |||
| New mortgage loans | 1,841,154 | 1,117,846 | 1,761,853 |
| Acquisition | 17,177 | 13,075 | 17,657 |
| Capitalized Interest | 1,403 | 2,395 | 1,604 |
| Deduction during period: | |||
| Collection of principal | (750,752) | (474,406) | (525,986) |
| Collection of capitalized interest | (1,463) | (570) | (2,155) |
| Foreclosures | (51,553) | (52,208) | (10,031) |
| Mortgages sold | (72,919) | (45,728) | (317,676) |
| Balance at end of period | $5,055,937 | $4,072,890 | $3,512,486 |
Note 8— Receivables Due from Servicers
The following tables summarize receivables due from servicers as of December 31, 2024 and 2023:
| Securitized Debt | Warehouse and Repurchase Facilities and Other | Total | |
|---|---|---|---|
| (In thousands) | |||
| Loan principal payments due from servicers | $61,907 | $1,695 | $63,602 |
| Other loan servicing receivables | 17,246 | 5,404 | 22,650 |
| Loan servicing receivables | 79,153 | 7,099 | 86,252 |
| Corporate and escrow advances receivable | 33,387 | 3,855 | 37,242 |
| Total receivables due from servicers | $112,540 | $10,954 | $123,494 |
| Securitized Debt | Warehouse and Repurchase Facilities and Other | Total | |
|---|---|---|---|
| (In thousands) | |||
| Loan principal payments due from servicers | $41,289 | $136 | $41,425 |
| Other loan servicing receivables | 13,122 | 3,249 | 16,371 |
| Loan servicing receivables | 54,411 | 3,385 | 57,796 |
| Corporate and escrow advances receivable | 25,736 | 1,545 | 27,281 |
| Total receivables due from servicers | $80,147 | $4,930 | $85,077 |
Note 9 — Property and Equipment, Net
As of December 31, 2024 and 2023, property and equipment consisted of the following:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In thousands) | ||
| Furniture | $781 | $930 |
| Computer equipment | 982 | 986 |
| Office equipment | 282 | 409 |
| Leasehold improvements | 577 | 609 |
| Capitalized software | 7,010 | 6,784 |
| Building | — | 685 |
| 9,632 | 10,403 | |
| Accumulated depreciation and amortization | (7,982) | (7,618) |
| Ending balance | $1,650 | $2,785 |
For each of the years ended December 31, 2024, 2023 and 2022, depreciation and amortization expense was$0.8 million.
The Company engaged a third-party consulting firm to assist in the building and implementation of a data warehouse and loan origination systems. The data warehouse was placed into service in 2017 and the loan origination system (“LOS”) was placed into service in 2018. The total capitalized costs for the data warehouse and the LOS were$5.7 million as of December 31, 2024 and 2023. Total accumulated depreciation and amortization included accumulated amortization on the data warehouse and the LOS of$4.8 million and$4.4 million as of December 31, 2024 and 2023, respectively. The estimated aggregate amortization expense related to capitalized software for each of the next five years is$0.4 million for 2025 and 2026, $0.2 million for 2027, $0.1 million for 2028, andnone thereafter.
Note 10 — Real Estate Owned, Net
The Company’s real estate owned activities were as follows during the years ended December 31, 2024, 2023 and 2022:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Beginning balance | $44,268 | $13,325 | $17,557 |
| Additions | 58,556 | 56,025 | 13,439 |
| Sales | (28,703) | (21,179) | (19,558) |
| Other adjustments | — | — | 2,250 |
| Valuation adjustments | (6,121) | (3,903) | (363) |
| Ending balance | $68,000 | $44,268 | $13,325 |
As of December 31, 2024, the carrying value of real estate owned was$68.0 million, of which$10.2 million were pledged as collateral under a warehouse repurchase agreement. As of December 31, 2023, the carrying value of real estate owned was$44.3 million, andnone were pledged as collateral under any warehouse repurchase agreement.
The following table summarizes information about real estate operating income and expenses, realized gains and losses on sales of real estate, and unrealized gains and losses resulting from adjustments to valuation allowances for the years ended December 31,2024, 2023 and 2022:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Operating income | $387 | $— | $275 |
| Operating expenses | (4,571) | (2,818) | (2,781) |
| Valuation adjustments | (6,121) | (3,903) | (363) |
| Net gain on sales of real estate | 4,275 | 568 | 2,939 |
| Total | $(6,030) | $(6,153) | $70 |
Net gain (loss) on sales of real estate represents the difference between the net proceeds from the liquidation of the underlying properties and their respective carrying values. The following table provides additional information about the number of properties sold and the gross gains and losses recognized in “Real estate owned, net”, in the Consolidated Statements of Income, for the years ended December 31,2024, 2023 and 2022:
| Year Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | ||||
| PropertiesSold | Gain (Loss) | PropertiesSold | Gain (Loss) | PropertiesSold | Gain (Loss) | |
| ($ in thousands) | ||||||
| Sales resulting in gains | 41 | $5,102 | 24 | $1,442 | 31 | $3,401 |
| Sales resulting in losses | 21 | (827) | 19 | (874) | 12 | (462) |
| Total | 62 | $4,275 | 43 | $568 | 43 | $2,939 |
Note 11 — Mortgage Servicing Rights
Mortgage loans serviced for others are not included in the Consolidated Balance Sheets. The unpaid principal balance of mortgage loans serviced for others by Century amounted to$807.9 million and$490.9 million as of December 31, 2024, and 2023, respectively. The Company has elected to record its mortgage servicing rights using the fair value measurement method. Significant assumptions used in determining the fair value of servicing rights as of December 31, 2024, 2023 and 2022 include: (1) Weighted average discount rate of 8.0%,8.0% and 8.1%, respectively, and (2) Weighted average constant prepayment rate of 5.1%,6.5% and 6.3%, respectively.
The following table presents the Company’s mortgage servicing rights for the years ended December 31, 2024, 2023 and 2022:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Balance at the beginning of year | $8,578 | $9,238 | $7,152 |
| Mortgage servicing rights acquired | 4,759 | — | — |
| Fair value adjustments | 375 | (660) | 2,086 |
| Balance at end of year | $13,712 | $8,578 | $9,238 |
Note 12 — Derivative Instruments
In September 2023, the Company began utilizing forward starting interest rate swap derivative instruments designated as cash flow hedges to manage the exposure to interest rate volatility related to its forecasted issuances of fixed-rate debt through its securitization process. The Company’s risk management objective is to hedge the risk of variability in its interest payment cash flows attributable to changes in the benchmark SOFR between the time the fixed rate mortgages are originated and the fixed rate debt is issued. As of December 31, 2024, the maximum length of time over which the Company was hedging its exposure to variability in future cash flows for forecasted transactions did not exceed four years.
The gains or losses on the derivative instruments that are designated and qualify as cash flow hedges are reported as a component of AOCI. Beginning in the period in which the forecasted debt is issued and the related derivative instruments are terminated, the accumulated gains or losses associated with the terminated derivatives are then reclassified into interest expense as a yield adjustment over the term of the related debt. For the years ended December 31, 2024 and 2023,$14 thousand and$50 thousand of after-tax net gains, respectively, on terminated derivative instruments, were reclassified from AOCI tointerest expense. As of December 31, 2024 and 2023, the Company had$0.8 million and$1.2 million, respectively, of after-tax net unrealized losses associated with cash flow hedging instruments recorded in AOCI. As of December 31, 2024, the Company expects to reclassify an estimated$22 thousand of after-tax net unrealized loss on derivative instruments designated as cash flow hedges from AOCI into earnings over the next 12 months.
The following tables present the fair value of the Company’s derivative financial instruments on a gross basis, as well as its classification on the Company’s Consolidated Balance Sheets as of December 31, 2024 and 2023:
| Derivatives designated as hedging instruments: | Balance Sheet Location | Notional Amount | Fair Value (1) |
|---|---|---|---|
| Cash flow hedges: · (In thousands) | |||
| Forward starting payer interest rate swaps | Derivative liability | $— | $— |
| Derivatives designated as hedging instruments: | Balance Sheet Location | Notional Amount | Fair Value (1) |
|---|---|---|---|
| Cash flow hedges: · (In thousands) | |||
| Forward starting payer interest rate swaps | Derivative liability | $166,000 | $3,655 |
(1)
Fair value reported is exclusive of collateral held and pledged, related to derivative exposure between the Company and its derivative counterparty. As of December 31, 2024, no collateral was pledged to its derivative counterparty. As of December 31, 2023, collateral pledged to its derivative counterparty was$4.2 million. These amounts were included in “Other receivables” in the Consolidated Balance Sheets.
The counterparty to the financial derivatives that the Company entered into is a major institution. The Company is exposed to credit-related losses in the event of non-performance by the counterparty. This credit risk is generally limited to the unrealized gains in such contracts, less collateral held, should the counterparty fail to perform as contracted.
Note 13 — Accumulated Other Comprehensive Income (Loss)
There were no accumulated other comprehensive income for the year ended December 31, 2022. The following table presents the changes in the components of accumulated other comprehensive income (loss) balances for the years ended December 31, 2024 and 2023:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In thousands) | ||
| Beginning balance | $(1,210) | $— |
| Net unrealized gain (loss) on cash flow hedges arising during the period, net of tax | 419 | (1,160) |
| Reclassification adjustments included in net income | (14) | (50) |
| Ending balance | $(805) | $(1,210) |
The following table presents the components of other comprehensive income (loss) and the related tax effect for the years ended December 31, 2024 and 2023:
| December 31, | ||||||
|---|---|---|---|---|---|---|
| 2024 | 2023 | |||||
| Before-Tax | Tax Effect | Net-of-Tax | Before-Tax | Tax Effect | Net-of-Tax | |
| (In thousands) | ||||||
| Cash flow hedges: | ||||||
| Forward starting payer interest rate swaps: | ||||||
| Net unrealized gain (loss) arising during the period | $583 | $(164) | $419 | $(1,568) | $408 | $(1,160) |
| Reclassification adjustments included in net income | (19) | 5 | (14) | (69) | 19 | (50) |
| Other comprehensive income (loss) | $564 | $(159) | $405 | $(1,637) | $427 | $(1,210) |
Note 14 — Goodwill
FASB ASC 350, Intangibles - Goodwill and Other, requires a company to perform an impairment test on goodwill annually, or more frequently if events or changes in circumstance indicate that the asset might be impaired, by comparing the fair value of such goodwill to its recorded or carrying amount. If the carrying amount of goodwill exceeds the fair value, an impairment charge must be recorded in an amount equal to the excess. The goodwill was recorded as part of the purchase accounting of Century on December 28, 2021, Management has assessed goodwill and concluded thatno impairment existed as of December 31, 2024 and 2023.
The following table presents the activity for goodwill for the years ended December 31, 2024 and 2023:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In thousands) | ||
| Balance at the beginning of year | $6,775 | $6,775 |
| Goodwill acquired | — | — |
| Balance at end of year | $6,775 | $6,775 |
Note 15 — Other Assets
Other assets were comprised of the following as of December 31,2024 and 2023:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In thousands) | ||
| Prepaid expenses | $2,145 | $2,026 |
| Deposits | 210 | 190 |
| Deferred costs | 840 | 500 |
| Operating leases - right of use assets, net | 2,501 | 2,544 |
| Appraisal fees for loans in process | (201) | (172) |
| Other assets | 179 | 160 |
| Total other assets | $5,674 | $5,248 |
Note 16 — Leases
The Company adopted ASU 2016-02, Leases(Topic 842) and all subsequent related ASUs using the alternative transition method effective January 1, 2019. The Company has elected the package of practical expedients that permits the Company to not reassess prior conclusions about lease identification, lease classification and initial direct costs. The Company also elected all the new standard’s available transition practical expedients, including the short-term lease recognition exemption that includes not recognizing right-of-use (“ROU”) assets or lease liabilities for existing short-term leases, and the practical expedient to not separate lease and non-lease components for all leases.
The Company determines if a contract arrangement is a lease at inception. The Company primarily enters into operating lease contracts for office space and certain equipment. As part of the property lease agreements, the Company may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options. The ROU lease asset also includes any lease payments made and lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company does not possess any leases that have variable lease payments or residual value guarantees.
The Company uses its incremental borrowing rates to determine the present value of its lease liabilities. The weighted average borrowing rate was 8.80%,7.72% and 5.88% as of December 31, 2024, 2023 and 2022, respectively. The Company’s leases have remaining terms ranging fromtwo years tofive years, and the weighted average remaining lease term was 5.0 years as of December 31, 2024. Short-term leases (initial term of less than 12 months) are not recorded on the balance sheet and lease expense is recognized on a straight-line basis over the lease term.
As of December 31, 2024 and 2023, operating lease ROU assets included inother assets were$2.5 million. Operating lease liabilities included in accounts payable and accrued expenses remained at$2.7 million as of December 31, 2024, and 2023. Operating lease expense is a component of “Rent and occupancy” on the Consolidated Statements of Income. Operating lease expense was$1.9 million,$1.9 million and$1.7 million for the years ended December 31, 2024, 2023 and 2022, respectively, and included short-term leases that were immaterial.
The following table presents supplemental cash flow information related to leases for the years ended December 31,2024, 2023 and 2022:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Cash paid for amounts included in the measurement of lease liabilities: | |||
| Operating cash flows from operating leases | $1,416 | $1,602 | $1,632 |
| ROU assets obtained in exchange for lease obligations: | |||
| Operating leases | $1,180 | $1,689 | $26 |
The following table presents maturities of operating lease liabilities as of December 31, 2024:
| (In thousands) | |
|---|---|
| 2025 | $732 |
| 2026 | 604 |
| 2027 | 649 |
| 2028 | 616 |
| 2029 | 364 |
| Thereafter | 405 |
| Total lease payments | 3,370 |
| Less: Imputed interest | (670) |
| Present value of lease liabilities | $2,700 |
Note 17 — Securitized Debt at Amortized Cost and Securitized Debt at Fair Value
The following tables summarize securitized debt at amortized cost and securitized debt at fair value as of December 31,2024 and 2023:
| December 31, | ||
|---|---|---|
| Securitized Debt at Amortized Cost | 2024 | 2023 |
| (In thousands) | ||
| Unpaid principal balance | $2,049,790 | $2,458,439 |
| Deferred issuance costs and discounts | (30,734) | (39,628) |
| Total securitized debt at amortized cost | $2,019,056 | $2,418,811 |
| December 31, | ||
|---|---|---|
| Securitized Debt at Fair Value | 2024 | 2023 |
| (In thousands) | ||
| Unpaid principal balance | $2,219,218 | $876,704 |
| Adjustment at issuance to recognize fair value (1) | (18,231) | (8,289) |
| Fair value at issuance | 2,200,987 | 868,415 |
| Valuation adjustment subsequent to issuance (2) | 6,421 | 9,002 |
| Total securitized debt at fair value | $2,207,408 | $877,417 |
(1)
Balance sheet adjustment to recognize fair value at issuance. This valuation adjustment is not recognized in net income.
(2)
Valuation adjustment recognized in net income. No valuation change is due to instrument specific credit risk as the Company’s (issuer) credit risk has not changed.
The following tables present the difference between the aggregate fair value and the aggregate unpaid principal balance of securitized debt at fair value as of December 31, 2024 and 2023:
| Fair Value | Unpaid Principal Balance | Difference | |
|---|---|---|---|
| (In thousands) | |||
| December 31, 2024 | $2,207,408 | $2,219,218 | $(11,810) |
| December 31, 2023 | 877,417 | 876,704 | 713 |
The following table presents the effective interest rate of securitized debt at amortized cost and securitized debt at fair value for the years ended December 31,2024, 2023 and 2022:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| ($ in thousands) | |||
| Interest expense | $220,427 | $164,742 | $110,268 |
| Average outstanding unpaid principal balance | 3,780,660 | 3,113,500 | 2,458,332 |
| Effective interest rate (1) | 5.83% | 5.29% | 4.49% |
(1)
Effective interest rate represents annualized interest expense divided by average gross outstanding balance, which includes average rates of 5.60%,4.79% and 3.78% and debt issuance cost amortization of 0.23%,0.50% and 0.71% as of December 31, 2024, 2023 and 2022, respectively.
As of December 31, 2024, the Company is the sole beneficial interest holder oftwenty-nine Trusts, which are variable interest entities included in the consolidated financial statements. The transactions are accounted for as secured borrowings under U.S. GAAP. The securities are subject to redemption by the Company when the stated principal balance is less than a certain percentage, ranging from 10% to 30% of the original stated principal balance of loans at issuance. As a result, the actual maturity dates of the securities issued could be earlier than their respective stated maturity dates. The following table summarizes securities issued, ownership retained by the Company at the time of the securitization, and as of December 31,2024 and 2023, and the stated maturity for each outstanding securitized debt:
| Securities Retained as of | |||||
|---|---|---|---|---|---|
| Trusts | SecuritiesIssued | IssuanceDate | December 31,2024 | December 31,2023 | Stated MaturityDate |
| (In thousands) | |||||
| 2017-2 Trust | $245,601 | $12,927 | $2,416 | $2,416 | October 2047 |
| 2018-1 Trust | 176,816 | 9,308 | 1,602 | 1,602 | April 2048 |
| 2018-2 Trust | 307,988 | 16,210 | 2,698 | 3,614 | October 2048 |
| 2019-1 Trust | 235,580 | 12,399 | — | — | March 2049 |
| 2019-2 Trust | 207,020 | 10,901 | — | — | July 2049 |
| 2019-3 Trust | 154,419 | 8,127 | — | — | October 2049 |
| 2020-1 Trust | 248,700 | 13,159 | — | — | February 2050 |
| 2020-2 Trust | 96,352 | 32,118 | — | 12,847 | June 2050 |
| 2021-1 Trust | 251,301 | 13,227 | — | — | May 2051 |
| 2021-2 Trust | 194,918 | 10,260 | — | — | August 2051 |
| 2021-3 Trust | 204,205 | — | — | — | October 2051 |
| 2021-4 Trust | 319,116 | — | — | — | December 2051 |
| 2022-1 Trust | 273,594 | 5,015 | 3,876 | 4,206 | February 2052 |
| 2022-2 Trust | 241,388 | 11,202 | 9,246 | 10,971 | March 2052 |
| 2022-MC1 Trust | 84,967 | 40,911 | 47,936 | 45,026 | May 2047 |
| 2022-3 Trust | 296,323 | 18,914 | 15,489 | 15,489 | May 2052 |
| 2022-4 Trust | 308,357 | 25,190 | 10,362 | 13,414 | July 2052 |
| 2022-5 Trust | 188,754 | 65,459 | 12,649 | 12,649 | October 2052 |
| 2023-1 Trust | 198,715 | 41,593 | 4,043 | 4,043 | December 2052 |
| 2023-1R Trust | 64,833 | 66,228 | 66,228 | 66,228 | October 2025 |
| 2023-2 Trust | 202,210 | 24,229 | 6,714 | 23,948 | April 2053 |
| 2023-RTL1 Trust | 81,608 | 4,296 | 4,296 | 4,296 | July 2028 |
| 2023-3 Trust | 234,741 | 28,718 | 9,146 | 28,480 | July 2053 |
| 2023-4 Trust | 202,890 | 26,623 | 3,995 | 26,482 | November 2053 |
| 2024-1 Trust | 209,862 | 11,278 | 11,229 | — | January 2054 |
| 2024-2 Trust | 286,235 | 8,853 | 8,767 | — | April 2054 |
| 2024-3 Trust | 204,599 | 5,255 | 5,211 | — | June 2054 |
| 2024-4 Trust | 253,612 | 3,080 | 3,064 | — | July 2054 |
| 2024-5 Trust | 292,880 | 7,510 | 7,481 | — | October 2054 |
| 2024-6 Trust | 293,895 | 7,690 | 7,687 | — | December 2054 |
| Total | $6,561,479 | $540,680 | $244,135 | $275,711 | |
The following table summarizes outstanding bond balances for each securitized debt as of December 31,2024 and 2023:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In thousands) | ||
| 2017-2 Trust | $33,012 | $45,869 |
| 2018-1 Trust | 24,482 | 33,505 |
| 2018-2 Trust | 59,091 | 76,871 |
| 2019-1 Trust | 60,459 | 76,391 |
| 2019-2 Trust | 46,872 | 66,340 |
| 2019-3 Trust | 46,827 | 58,089 |
| 2020-1 Trust | 91,135 | 106,976 |
| 2020-2 Trust | — | 45,180 |
| 2021-1 Trust | 152,995 | 171,748 |
| 2021-2 Trust | 125,391 | 143,797 |
| 2021-3 Trust | 136,510 | 158,043 |
| 2021-4 Trust | 214,284 | 244,919 |
| 2022-1 Trust | 217,190 | 236,358 |
| 2022-2 Trust | 191,764 | 210,217 |
| 2022-MC1 Trust | 12,041 | 31,508 |
| 2022-3 Trust | 234,647 | 257,047 |
| 2022-4 Trust | 232,064 | 274,419 |
| 2022-5 Trust | 132,519 | 162,925 |
| 2023-1 Trust | 144,724 | 177,250 |
| 2023-1R Trust | 38,508 | 58,237 |
| 2023-2 Trust | 157,198 | 188,805 |
| 2023-RTL1 Trust | 81,608 | 81,608 |
| 2023-3 Trust | 195,799 | 227,228 |
| 2023-4 Trust | 181,307 | 201,813 |
| 2024-1 Trust | 178,234 | — |
| 2024-2 Trust | 260,500 | — |
| 2024-3 Trust | 191,583 | — |
| 2024-4 Trust | 243,945 | — |
| 2024-5 Trust | 290,552 | — |
| 2024-6 Trust | 293,767 | — |
| Total outstanding bond balance | $4,269,008 | $3,335,143 |
Prior to 2023, the securities and certificates were typically issued at a discount to par, which was recorded as a contra liability to the securities issued. Securitized debt accounted for under the FVO accounting has no discounts or premiums. Discounts or premiums on securitized debt carried at amortized cost are amortized as an adjustment of yield over the stated term of the related securitized debt adjusted for prepayments. As of December 31,2024 and 2023, unamortized discounts associated with securities carried at amortized cost were as follows:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In thousands) | ||
| 2017-2 Trust | $4 | $6 |
| 2018-1 Trust | 2 | 3 |
| 2018-2 Trust | 6 | 8 |
| 2019-1 Trust | 5 | 6 |
| 2019-2 Trust | 3 | 4 |
| 2019-3 Trust | 2 | 3 |
| 2020-1 Trust | 2 | 2 |
| 2020-2 Trust | — | 294 |
| 2021-Trust | 9 | 11 |
| 2021-2 Trust | 112 | 127 |
| 2021-3 Trust | 382 | 473 |
| 2021-4 Trust | 409 | 474 |
| 2022-1 Trust | 2,049 | 2,622 |
| 2022-2 Trust | 2,286 | 2,784 |
| 2022-MC1 Trust | 45 | 189 |
| 2022-3 Trust | 3,878 | 4,552 |
| 2022-4 Trust | 2,883 | 3,689 |
| 2022-5 Trust | 412 | 544 |
| 2023-1R Trust | 248 | 967 |
| Total unamortized discounts | $12,737 | $16,758 |
Other than securitized debt carried at fair value, professional and other capitalized issuance costs associated with securitized debt were recorded as a contra liability to the securities issued. As of December 31,2024 and 2023, capitalized issuance costs associated with the Trusts were as follows:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In thousands) | ||
| 2017-2 Trust | $263 | $392 |
| 2018-1 Trust | 128 | 185 |
| 2018-2 Trust | 463 | 627 |
| 2019-1 Trust | 342 | 432 |
| 2019-2 Trust | 434 | 597 |
| 2019-3 Trust | 374 | 471 |
| 2020-1 Trust | 744 | 927 |
| 2020-2 Trust | — | 115 |
| 2021-1 Trust | 1,128 | 1,392 |
| 2021-2 Trust | 1,093 | 1,347 |
| 2021-3 Trust | 1,261 | 1,563 |
| 2021-4 Trust | 2,021 | 2,382 |
| 2022-1 Trust | 2,091 | 2,252 |
| 2022-2 Trust | 1,796 | 2,188 |
| 2022-MC1 Trust | 103 | 426 |
| 2022-3 Trust | 2,319 | 2,721 |
| 2022-4 Trust | 1,952 | 2,498 |
| 2022-5 Trust | 1,332 | 1,760 |
| 2023-1R Trust | 153 | 595 |
| Total capitalized issuance costs | $17,997 | $22,870 |
As of December 31,2024 and 2023, the weighted average rates on the sold securities and certificates for the Trusts were as follows:
| December 31, | ||||
|---|---|---|---|---|
| 2024 · 2023 | ||||
| 2017-2 Trust | 4.09 | % | 3.97 | % |
| 2018-1 Trust | 4.13 | 4.03 | ||
| 2018-2 Trust | 4.47 | 4.48 | ||
| 2019-1 Trust | 4.07 | 4.07 | ||
| 2019-2 Trust | 3.41 | 3.42 | ||
| 2019-3 Trust | 3.30 | 3.29 | ||
| 2020-1 Trust | 2.88 | 2.85 | ||
| 2020-2 Trust | 4.63 | 4.61 | ||
| 2021-1 Trust | 1.76 | 1.76 | ||
| 2021-2 Trust | 2.04 | 2.02 | ||
| 2021-3 Trust | 2.47 | 2.46 | ||
| 2021-4 Trust | 3.25 | 3.22 | ||
| 2022-1 Trust | 3.94 | 3.93 | ||
| 2022-2 Trust | 5.06 | 5.07 | ||
| 2022-MC1 Trust | 6.90 | 6.90 | ||
| 2022-3 Trust | 5.72 | 5.70 | ||
| 2022-4 Trust | 6.21 | 6.24 | ||
| 2022-5 Trust | 7.04 | 7.06 | ||
| 2023-1 Trust | 7.02 | 7.02 | ||
| 2023-1R Trust | 7.57 | 7.68 | ||
| 2023-2 Trust | 7.33 | 7.19 | ||
| 2023-RTL1 Trust | 8.24 | 8.24 | ||
| 2023-3 Trust | 7.94 | 7.82 | ||
| 2023-4 Trust | 8.33 | 8.38 | ||
| 2024-1 Trust | 7.75 | — | ||
| 2024-2 Trust | 7.11 | — | ||
| 2024-3 Trust | 7.20 | — | ||
| 2024-4 Trust | 7.08 | — | ||
| 2024-5 Trust | 6.14 | — | ||
| 2024-6 Trust | 5.92 | — | ||
Note 18 — Other Debt
Secured financing and warehouse facilities are utilized to finance the origination and purchase of commercial real estate mortgage loans. Warehouse facilities are designated to fund mortgage loans that are purchased and originated within specified underwriting guidelines. Most of these lines of credit fund less than 100% of the principal balance of the mortgage loans originated and purchased, requiring the use of working capital to fund the remaining portion.
(a)
Secured Financing, Net (“Corporate Debt”)
On March 15, 2022, the Company entered into afive-year $215.0 million syndicated corporate debt agreement (“the 2022 Term Loan”). The 2022 Term Loan bears interest at a fixed rate of 7.125% and matures on March 15, 2027. Interest on the 2022 Term Loan is paid everysix months. A portion of the net proceeds from the 2022 Term Loan was used to redeem all the amounts owed pursuant to a term loan previously entered into during 2021 (“the 2021 Term Loan”). The remaining portion of the net proceeds from the 2022 Term Loan is used for loan originations and general corporate purposes. As of December 31, 2024 and 2023, the balance of the 2022 Term Loan was $215.0 million.
On February 5, 2024, the Company entered into afive-year $75.0 million syndicated corporate debt agreement, the (“the 2024 Term Loan”). The 2024 Term Loan bears interest at 9.875% and matures on February 15, 2029. Interest on the 2024 Term Loan is paid every six months. As of December 31, 2024, the balance of the 2024 Term Loan was $75.0 million.
The total balance of the 2022 Term Loan and the 2024 Term Loan (“Corporate Debt”) in the Consolidated Balance Sheets is net of debt issuance costs of$5.2 million and$3.9 million as of December 31, 2024 and 2023, respectively. The Corporate Debt is secured by substantially all assets of the Company not otherwise pledged under a securitized debt or warehouse facility and contains certain reporting and financial covenants. Should the Company fail to adhere to those covenants, the lenders have the right to demand immediate repayment that may require the Company to sell the collateral at less than the carrying amounts. As of December 31, 2024, the Company was in compliance with all covenants.
(b)
Warehouse Repurchase and Revolving Loan Facilities, Net
On January 4, 2011, Century entered into a Master Participation and Facility Agreement with a bank (“the September 2022 Term Repurchase Agreement”). The Facility Agreement has a current extended maturity date of July 31, 2025, and is a short-term borrowing facility, collateralized by performing loans, with a maximum capacity of $60.0 million, and bears interest atone-month SOFR plus 1.60% with a 0.25% floor.
On May 17, 2013, the Company entered into a Repurchase Agreement (“the 2013 Repurchase Agreement”) with a warehouse lender. The 2013 Repurchase Agreement is a modified mark-to-market agreement and has a current maturity date of September 25, 2025, and is a short-term borrowing facility, collateralized by a pool of performing loans, with a maximum capacity of $300.0 million, and bears interest at SOFR plus 3.00%. All borrower payments on loans financed under the warehouse repurchase facility are first used to pay interest on the facility.
On September 12, 2018, the Company entered into athree-year non-mark-to-market secured revolving loan facility agreement (“the Bank Credit Agreement”) with a bank. The Bank Credit Agreement has a current extended maturity date of November 10, 2025. During the borrowing period, the Company can take loan advances from time to time subject to availability. Each loan advance bears interest at SOFR plus 3.61%, with a floor of 4.25%. The maximum loan amount under this facility is $50.0 million. The agreement was paid off in November 2024 from the advance of the 2024 Bank Credit Agreement.
On January 29, 2021, the Company entered into a non-mark-to-market Repurchase Agreement (“the 2021 Repurchase Agreement”) with a warehouse lender. The 2021 Repurchase Agreement has a current extended maturity date of May 20, 2025, and is a short-term borrowing facility, collateralized by a pool of loans. On July 25, 2024, the Company entered into a mark-to-market Repurchase Agreement (“the 2024 Repurchase Agreement”) with the same warehouse lender. The 2024 Repurchase Agreement also has a maturity date of May 20, 2025, and is a short-term borrowing facility, collateralized by a pool of loans. The maximum capacity under both agreements is $200.0 million individually and in the aggregate. The 2024 Repurchase Agreement includes a $75.0 million sublimit for nonperforming loans. Borrowings under these two facilities bear interest at SOFR plus a margin of 3.00% during the availability period and 4.00% during the amortization period. All borrower payments on loans financed under the warehouse repurchase facilities are first used to pay interest on the facilities.
On April 16, 2021, The Company entered into a non-mark-to-market Term Repurchase Agreement (“the 2021 Term Repurchase Agreement”) with a warehouse lender. The 2021 Term Repurchase Agreement has a maturity date of April 16, 2026, with a borrowing period through April 14, 2025. During the borrowing period, the Company can take loan advances from time to time subject to availability. Each loan advance bears interest at SOFR plus a margin of 3.10%. The maximum capacity under this facility is $100.0 million.
On July 29, 2021, the Company entered into a non-mark-to-market Term Repurchase Agreement (“the July 2021 Term Repurchase Agreement”) with a warehouse lender. The July 2021 Term Repurchase Agreement has a maturity date of August 9, 2024, with an option to extend the term to July 29, 2025. During the borrowing period, the Company can take loan advances from time to time subject to availability. Each loan advance bears interest at one-month American Interbank Offered Rate (“AMERIBOR”) with a 0.5% floor plus 4.50% per annum. The maximum capacity under this facility is $100.0 million. The agreement was paid off in August 2024 from the 2024 Repurchase Agreement proceeds.
On October 12, 2023, the Company entered into a $9.5 million short-term repurchase agreement (“the October 2023 Repurchase Agreement”), andbore interest at 7.0%. On December 14, 2023, the Company entered into two $10.0 million short-term repurchase agreements, one agreement bore interest at 7.6%, and the other agreement bore interest at 7.5%. These repurchase agreements were paid off in February 2024.
On December 27, 2023, the Company entered into a loan facility agreement (“the 2023 Repurchase Agreement”) with a bank. The 2023 Repurchase Agreement has a maturity date of December 27, 2026. During the borrowing period, the Company can take loan advances from time to time subject to availability. Each loan advance bears interest at SOFR plus 3.00%. The maximum loan amount under this facility is $75.0 million.
On November 7, 2024, the Company entered into a non-mark-to-market secured revolving loan facility agreement (“the 2024 Bank Credit Agreement”) with a bank. The 2024 Bank Credit Agreement has a current maturity date of May 7, 2027. The eligible mortgage loan advance rate for performing loans is 82.5%, and the eligible past due loan and REO property advance rate is 55.0%. Each loan advance bears interest at SOFR plus 3.50%, with a floor of 2.00%. The maximum loan amount under this facility is $50.0 million.
Certain loans are pledged as collateral under the warehouse repurchase facilities and the revolving loan facility, which contain covenants. Should the Company fail to adhere to those covenants or otherwise default under the facilities, the lenders have the right to terminate the facilities and demand immediate repayment that may require the Company to sell the collateral at less than the carrying amounts. As of December 31, 2024 and 2023, the Company was in compliance with all covenants.
The following table summarizes the maximum borrowing capacity, current gross balances outstanding, and effective interest rates of the Company’s warehouse facilities and loan agreements as of December 31,2024 and 2023:
| December 31, | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 · 2023 | ||||||||||||
| Contract Date · Maturity Date · Period EndBalance (1) · MaximumBorrowingCapacity · Effective Interest Rate · Period EndBalance (1) · MaximumBorrowingCapacity · Effective Interest Rate | ||||||||||||
| ($ in thousands) | ||||||||||||
| The September 2022 term repurchase agreement | 01/04/2011 | 07/31/2025 | $— | $60,000 | 6.5 | % | $— | $60,000 | 6.2 | % | ||
| The 2013 repurchase agreement | 05/17/2013 | 09/25/2025 | 106,675 | 300,000 | 9.0 | 111,086 | 300,000 | 9.8 | ||||
| The bank credit agreement | 09/12/2018 | 11/10/2025 | — | — | 9.1 | 31,950 | 50,000 | 9.2 | ||||
| The 2021/2024 repurchase agreements | 1/29/20217/25/2024 | 05/20/2025 | 126,815 | 200,000 | 9.0 | 88,817 | 200,000 | 10.0 | ||||
| The 2021 term repurchase agreement | 04/16/2021 | 04/16/2026 | 52,408 | 100,000 | 8.5 | 30,460 | 100,000 | 8.3 | ||||
| The July 2021 term repurchase agreement(2) | 07/29/2021 | 07/29/2024 | — | — | 10.8 | 22,516 | 100,000 | 14.2 | ||||
| The October 2023 repurchase agreement | 10/12/2023 | 02/07/2024 | — | — | 7.3 | 29,522 | 30,530 | 6.8 | ||||
| The 2023 repurchase agreement | 12/27/2023 | 12/27/2026 | 44,900 | 75,000 | 9.7 | 22,000 | 50,000 | 8.6 | ||||
| The 2024 bank credit agreement | 11/07/2024 | 05/07/2027 | 19,248 | 50,000 | 9.2 | — | — | — | ||||
| Total | $350,046 | $785,000 | $336,351 | $890,530 | ||||||||
(1)
Warehouse repurchase facilities amounts in the Consolidated Balance Sheet are net of debt issuance costs amounting to$2.0 million and$1.6 million as of December 31, 2024 and 2023.
(2)
The July 2021 Term Repurchase Agreement was paid off in August 2024.
The following table provides an overview of the activity and effective interest rates of the Company’s warehouse facilities and loan agreements for the years ended December 31,2024, 2023 and 2022:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| ($ in thousands) | |||
| Average outstanding balance | $295,936 | $227,911 | $299,060 |
| Highest outstanding balance at any month-end | 460,108 | 336,351 | 426,959 |
| Effective interest rate (1) | 9.05% | 9.53% | 5.84% |
(1)
Effective interest rate represents interest expense divided by average gross outstanding balance. which includes average rate of 8.52%,8.76%, and 5.22%, and debt issue cost amortization of 0.53%,0.77% and 0.62%, for the years ended December 31, 2024, 2023 and 2022, respectively.
The following table provides a summary of interest expense that includes interest, amortization of discount, and deal cost amortization of the Company’s warehouse facilities and loan agreements for the years ended December 31,2024, 2023 and 2022:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Warehouse and repurchase facilities | $26,790 | $21,726 | $17,454 |
| Securitized debt | 220,428 | 164,742 | 110,269 |
| Interest expense — portfolio related | 247,218 | 186,468 | 127,723 |
| Interest expense — corporate debt | 23,821 | 16,556 | 29,472 |
| Total interest expense | $271,039 | $203,024 | $157,195 |
Note 19 —Income Taxes
The Company elected to be treated as a corporation, for tax purposes, effective January 1, 2018. The following table details the Company’s income tax expense (benefit):
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Current tax expense (benefit): | |||
| Federal | $27,810 | $13,631 | $(90) |
| State | 11,546 | 2,509 | 552 |
| Total current tax expense | 39,356 | 16,140 | 462 |
| Deferred tax expense (benefit): | |||
| Federal | (8,396) | 1,654 | 8,553 |
| State | (3,035) | 1,040 | 3,018 |
| Total deferred tax expense (benefit) | (11,431) | 2,694 | 11,571 |
| Total income tax expense | $27,925 | $18,834 | $12,033 |
The following table contains a reconciliation of the Company’s provision for income taxes at the federal statutory tax rate to the provision for income taxes at the effective tax rate as of December 31, 2024, 2023 and 2022:
| December 31, | ||||||
|---|---|---|---|---|---|---|
| 2024 · 2023 · 2022 | ||||||
| Federal income tax provision at statutory rate | 21.0 | % | 21.0 | % | 21.0 | % |
| State income taxes, net of federal tax benefit | 7.3 | 6.2 | 6.3 | |||
| Permanent items | 1.1 | 0.6 | 0.2 | |||
| Federal true-ups | 0.2 | 0.1 | — | |||
| Tax credits | (0.2) | (0.3) | (0.3) | |||
| Change in unrecognized tax benefit | (0.1) | (2.3) | — | |||
| Other | (0.3) | (0.1) | — | |||
| Effective tax rate | 29.0 | % | 25.2 | % | 27.2 | % |
The changes in state income taxes and unrecognized tax benefit in the reconciliation are primarily due to changes in state apportionment and the related valuation impacts on taxes payable as well as the deferred tax asset in the prior year.
The tax effects of temporary differences that give rise to deferred tax assets and deferred tax liabilities as of December 31, 2024 and 2023 are presented below:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In thousands) | ||
| Deferred tax assets: | ||
| REMIC book-tax basis difference | $9,220 | $— |
| Lease liability | 779 | 780 |
| Stock compensation | 834 | 1,779 |
| Accrued bonus | 144 | — |
| Accrued vacation | 521 | 386 |
| Intangibles | 1 | 3 |
| REO | 207 | 160 |
| Deferred state taxes | 510 | 374 |
| Research and experimental expenditures capitalization | 2,241 | 1,721 |
| MSR valuation allowance | — | 53 |
| Derivative - OCI | 294 | 427 |
| Deferred revenue | 1,053 | 1,038 |
| Gross deferred tax assets | 15,804 | 6,721 |
| Deferred tax liabilities: | ||
| REMIC book-tax basis difference | — | (2,522) |
| Mark-to-market on loans | (172) | (36) |
| Right-of-use assets | (721) | (735) |
| Deferred origination costs | (108) | (63) |
| Property and equipment | (157) | (332) |
| MSR valuation allowance | (246) | — |
| Other | (788) | (694) |
| Gross deferred tax liabilities | (2,192) | (4,382) |
| Total net deferred tax asset | $13,612 | $2,339 |
The Company’s main temporary difference is due to the difference between the U.S. income tax and U.S. GAAP treatment with respect to its REMIC securities. For tax purposes, the issuances are considered taxable sales, whereas, for U.S. GAAP purposes, the REMIC issuances are considered financings.
No Federal net operating loss (“NOL”) carryforwards were utilized to offset current U.S. federal taxable income in 2024, and $5.7 million were utilized to offset U.S. federal taxable income in 2023. No State NOL carryforwards were utilized to offset taxable income in 2024, and $2.5 million were utilized to offset taxable income in 2023. There were no additional NOL carryforwards after 2023.
The Company hadno valuation allowance as of December 31, 2024 and 2023. Based on the Company’s estimates of taxable income over the years in which the items giving rise to the deferred tax assets are deductible, management believes it is more likely than not the Company will realize the benefits of these deductible differences.
The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal, state, and local jurisdictions, where applicable. As of December 31, 2024, the Company is no longer subject to U.S. tax examinations for years before 2021 and is no longer subject to state tax examinations for years before 2020.
The Company periodically reviews its income tax positions based on tax laws and regulations and financial reporting considerations, and records adjustments as appropriate. This review takes into consideration the status of current taxing authorities’ examinations of the Company’s tax returns, recent positions taken by the taxing authorities on similar transactions, if any, and the overall tax environment.
The Company had gross unrecognized tax benefits in the amount of$0.3 million and$0.4 million recorded as of December 31, 2024 and 2023, respectively. If recognized,$0.3 million of the unrecognized tax benefits would affect the 2024 annual effective tax rate. Interest and penalties on unrecognized tax benefits were reported by the Company as a component of tax expense. The Company recorded interest and penalties in its Consolidated Statements of Income in the amount of$0.5 million and$0.1 million for the years ended December 31, 2023 and 2022, respectively. Interest and penalties for the year ended December 31, 2024 was immaterial. As of December 31, 2024 and 2023, the accrued interest and penalties related to unrecognized tax benefits were$33.8 thousand and$32.9 thousand, respectively.
There are no positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within 12 months of the reporting date.
Detailed below is a reconciliation of the Company’s gross unrecognized tax benefits for the years ended December 31, 2024, 2023 and 2022, respectively:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Beginning balance | $390 | $1,940 | $1,911 |
| Changes related to current year tax positions | 61 | 93 | 68 |
| Changes related to prior year tax positions | (33) | 25 | 19 |
| Decreases due to lapsed statutes of limitations | (113) | (1,668) | (58) |
| Ending balance | $305 | $390 | $1,940 |
Note 20 — Stock-Based Compensation
The Company’s Amended and Restated 2020 Omnibus Incentive Plan, or “the 2020 Plan”, authorizes grants of stock-based compensation instruments including but not limited to non-qualified stock options, restricted stock awards (“RSAs”) and performance stock unit awards (“PSUs”) to certain employees and non-employee directors of the Company, to purchase or issue up to 2,770,000 shares of the Company's common stock.
Expenses related to the stock-based compensation instruments and Employee Stock Purchase Plan (“ESPP”) are included in “Compensation and employee benefits” and “Other operating expenses” on the Consolidated Statements of Income.
Beloware summaries of the recognized and unrecognized stock-based compensation expense by instrument for the periods indicated:
| For the Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Recognized compensation expense: | |||
| Options | $205 | $55 | $1,017 |
| RSAs | 2,383 | 2,729 | 1,744 |
| PSUs | 2,839 | 912 | 379 |
| ESPP | 728 | 432 | 203 |
| Total recognized compensation expense | $6,155 | $4,128 | $3,343 |
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Unrecognized compensation expense: | |||
| Options | $1,363 | $22 | $52 |
| RSAs | 3,197 | 2,185 | 2,648 |
| PSUs | 2,508 | 1,544 | 920 |
| ESPP | 376 | — | — |
| Total unrecognized compensation expense | $7,444 | $3,751 | $3,620 |
| Weighted average period expected to be recognized (in years) | |||
| Options | 2.6 | 2.7 | 0.2 |
| RSAs | 1.8 | 1.7 | 1.6 |
(a)
Stock Options
Stock option awards provide for the option to purchase the Company's common stock. The stock options generally vest ratably over a service period of three years from the date of the grant.
The Company uses the Black-Scholes option pricing model to value stock options in determining the stock-based compensation expense. The compensation expense is recognized over thethree-year vesting period using the straight-line method. Forfeitures are recognized as they occur. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The expected dividend yield was zero as the Company does not expect to pay dividends in the foreseeable future. Expected volatility is based on average historical volatilities of the Company’s common stock.
The following table presents the assumptions used in the option pricing model at the grant date for options granted during the years ended December 31, 2024, 2023 and 2022:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Expected volatility | 30.00% - 40.00% | 28.00% | 28.00% |
| Risk-free interest rate | 4.60% - 5.33% | 1.50% | 1.50% |
| Expected term (in years) | 10.0 | 10.0 | 10.0 |
| Expected dividends | — | — | — |
The table below summarizes stock option activity during the years ended December 31, 2024, 2023 and 2022:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| ($ in thousands, except per share amounts) | |||
| Number of shares: | |||
| Options outstanding at beginning of year | 752,964 | 785,000 | 785,000 |
| Granted | 312,808 | 5,464 | — |
| Exercised | — | (37,500) | — |
| Forfeited | — | — | — |
| Options outstanding at end of year | 1,065,772 | 752,964 | 785,000 |
| Options exercisable at end of year | 749,321 | 747,500 | 523,333 |
| Options expected to vest (1) | 316,484 | 5,464 | 261,667 |
| Weighted average exercise price per share: | |||
| Options outstanding at beginning of year | $12.88 | $12.89 | $12.89 |
| Granted | 18.27 | 11.68 | — |
| Exercised | — | 13.00 | — |
| Options outstanding at end of year | $14.46 | $12.88 | $12.89 |
| Options exercisable at end of year | 12.88 | 12.89 | 12.89 |
| Options expected to vest (1) | 18.19 | 11.68 | 12.89 |
| Aggregate Intrinsic value (2): | |||
| Options outstanding at end of year | $5,440 | $3,269 | $42 |
| Options exercisable at end of year | 5,002 | 3,239 | 28 |
| Options expected to vest (1) | 438 | 30 | 14 |
| Weighted average remaining contractual life (in years): | |||
| Options outstanding at end of year | 6.4 | 6.1 | 7.1 |
| Options exercisable at end of year | 5.1 | 6.1 | 7.1 |
| Options expected to vest (1) | 9.6 | 9.7 | 7.1 |
(1)
The number of options expected to vest reflects no expected forfeiture.
(2)
The aggregate intrinsic value represents the amount by which the fair value of underlying stock exceeds the “in-the-money” option exercise price.
No stock options were exercised during the years ended December 31, 2024 and 2022. During the year ended December 31, 2023,37,500 shares were exercised at $13.00 per share, resulting in $0.5 million cash received.
(b)
RSAs
The fair value of RSAs is determined based on the fair market value of the Company’s common shares on the grant date. The estimated fair value of RSAs is amortized as an expense over thethree-year requisite service period. The Company has elected to recognize forfeitures as they occur rather than estimating service-based forfeitures over the requisite service period.
The table below summarizes restricted stock award activity during the years ended December 31, 2024, 2023 and 2022:
| December 31, | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | |||||||
| Employee | Non-Employee Director | Total | Employee | Non-Employee Director | Total | Employee | Non-Employee Director | Total | |
| Number of shares: | |||||||||
| Unvested at beginning of year | 409,137 | 61,276 | 470,413 | 445,250 | 48,889 | 494,139 | 480,000 | 26,511 | 506,511 |
| Granted | 195,164 | 15,939 | 211,103 | 198,137 | 31,629 | 229,766 | 125,250 | 31,215 | 156,465 |
| Vested | (248,796) | (29,785) | (278,581) | (234,250) | (19,242) | (253,492) | (160,000) | (8,837) | (168,837) |
| Unvested at end of year | 355,505 | 47,430 | 402,935 | 409,137 | 61,276 | 470,413 | 445,250 | 48,889 | 494,139 |
| Weighted average grant date fair value per share: | |||||||||
| Unvested at beginning of year | $9.39 | $9.31 | $9.38 | $8.61 | $9.72 | $8.72 | $7.04 | $10.75 | $7.23 |
| Granted | 15.93 | 17.88 | 16.08 | 10.00 | 9.01 | 9.86 | 12.63 | 9.13 | 11.93 |
| Vested | 8.61 | 9.57 | 8.71 | 8.42 | 9.87 | 8.53 | 7.04 | 10.75 | 7.23 |
| Unvested at end of year | $13.52 | $12.03 | $13.35 | $9.39 | $9.31 | $9.38 | $8.61 | $9.72 | $8.72 |
(c)
PSUs
In February 2022, the Company began granting PSUs to certain employees, including named executive officers under the 2020 Plan. PSUs will vest based on the achievement of predetermined performance goals over performance periods determined by the Compensation Committee. PSUs are subject to forfeiture until predetermined performance conditions have been achieved. The Company recognizes share-based compensation expense for PSUs on a straight-line basis over the requisite service period of the award when it is probable that the performance conditions will be achieved. Compensation expense for PSUs with financial performance measures is measured using the fair value at the date of grant and recorded over each vesting period and may be adjusted over the vesting period based on interim estimates of performance against the pre-set objectives. The granted PSUs represent 100% of the original target award amounts vesting eligibility is based on performance and service conditions of distinct three-year service periods for each award. Accordingly, the number of shares issued at the end of any performance period could range between 0% and 200% of the original target award amount.
A summary of the PSU activity for the years ended December 31, 2024, 2023 and 2022 under the 2020 Omnibus Plan is presented below:
| December 31, | |||||||
|---|---|---|---|---|---|---|---|
| 2024 · 2023 · 2022 | |||||||
| Number of Shares · Weighted Average Grant Date Fair Value Per Share · Number of Shares · Weighted Average Grant Date Fair Value Per Share · Number of Shares · Weighted Average Grant Date Fair Value Per Share | |||||||
| Outstanding at beginning of year, unvested | 256,387 | (1) | $11.05 | 102,750 | $12.63 | — | $— |
| Granted | 157,994 | (1) | 15.86 | 153,637 | 10.00 | 102,750 | 12.63 |
| Performance adjustment | 102,750 | 12.63 | — | — | — | — | |
| Outstanding at end of year, unvested | 517,131 | $12.83 | 256,387 | $11.05 | 102,750 | $12.63 | |
(1)
The number of PSUs are presented at 100% of the specified target shares.
(c)
ESPP
In July 2022, the Company initiated an ESPP which allows permitted eligible employees to purchase shares of the Company’s common stock through payroll deductions of up to 15% of their eligible compensation, subject to certain limitations. The purchase price of the shares under the ESPP equals 85% of the lower of the fair market value of the Company’s common stock on either the first or last trading day of each six-month offering period. As of December 31, 2024, a total of 415,727 shares have been issued under the ESPP with 174,595,167,123 and 74,009 shares issued during the years ended December 31, 2024, 2023 and 2022, respectively.
Compensation expense for the ESPP is calculated as of the beginning of the offering period as the fair value of the employees’ purchase rights utilizing the Black-Scholes option valuation model and is recognized as a compensation expense over the offering period. The table below presents the fair value assumptions used for the periods indicated:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Expected volatility | 28.80% - 67.54% | 51.31% | 49.93% |
| Risk-free interest rate | 5.29% - 5.30% | 5.45% | 2.50% |
| Expected term (in years) | 0.5 | 0.5 | 0.5 |
| Grant date fair value per share | $15.79 - $18.06 | $11.78 | $11.31 |
| Dividend yield | — | — | — |
(d)
Treasury Stock
Treasury stock represent shares surrendered to the Company to satisfy tax withholding obligations in connection with the vesting or exercise of stock-based awards. During the years ended December 31, 2024, 2023 and 2022, shares withheld were 94,150,87,765 and 33,647, respectively, at an average price of$16.46,$9.81 and$13.61 per share, respectively.
Note 21 — Earnings Per Share
The two-class method is used in the calculation of basic and diluted earnings per share. Under the two-class method, earnings available to common shareholders for the period are allocated between common shareholders and participating securities according to dividends declared (or accumulated) and participation rights in undistributed earnings. Basic earnings per share is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock and resulted in the issuance of common stock that shared in earnings.
The following table presents the basic and diluted income per share calculations for the years ended December 31, 2024, 2023 and 2022:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands, except per share data) | |||
| Basic EPS: | |||
| Net income attributable to common shareholders | $68,419 | $52,273 | $32,211 |
| Less undistributed earnings attributable to unvested restricted stock awards | 834 | 753 | 491 |
| Net earnings attributable to common shareholders | $67,585 | $51,520 | $31,720 |
| Weighted average common shares outstanding | 32,653 | 32,206 | 31,913 |
| Basic earnings per common share | $2.07 | $1.60 | $0.99 |
| Diluted EPS: | |||
| Net income attributable to common shareholders | $68,419 | $52,273 | $32,211 |
| Weighted average common shares outstanding | 32,653 | 32,206 | 31,913 |
| Add dilutive effects for warrants | 2,410 | 2,020 | 2,025 |
| Add dilutive effects for stock options | 215 | 14 | 5 |
| Add dilutive effects of unvested restricted stock awards | 179 | 173 | 188 |
| Add dilutive effects of unvested performance-based stock units | 302 | 71 | — |
| Add dilutive effects of employee stock purchase plan | 1 | — | — |
| Weighted average diluted common shares outstanding | 35,760 | 34,484 | 34,131 |
| Diluted earnings per common share | $1.91 | $1.52 | $0.94 |
The following table sets forth the number of shares excluded from the computation of diluted earnings per share, as their inclusion would have been anti-dilutive:
| December 31, | ||||||
|---|---|---|---|---|---|---|
| 2024(1) | 2023 | 2022 | ||||
| (In thousands) | ||||||
| Stock options | 155 | 5 | 773 | |||
| Unvested restricted stock awards | 53 | — | — | |||
| Unvested performance-based stock units | — | — | — | |||
| Employee stock purchase plan | 54 | — | — | |||
| Shares equivalents excluded from EPS | 262 | 5 | 773 | |||
(1)
Weighted average.
Note 22 — Concentration of Risk
The Company originates and purchases loans secured by a broad spectrum of commercial property throughout the United States. As of December 31, 2024 and 2023, the geographic and property type concentrations of loans, by unpaid principal balance, were as follows:
| December 31, | ||||
|---|---|---|---|---|
| 2024 · 2023 | ||||
| Geographic concentration: | ||||
| California | 21.0 | % | 22.0 | % |
| New York | 16.3 | 18.3 | ||
| Florida | 12.7 | 13.4 | ||
| New Jersey | 7.5 | 7.3 | ||
| Texas | 5.4 | 4.4 | ||
| Other states (individually less than 5.0%) | 37.1 | 34.6 | ||
| Total | 100.0 | % | 100.0 | % |
| December 31, | ||||
|---|---|---|---|---|
| 2024 · 2023 | ||||
| Property type concentration: | ||||
| Investor 1-4 | 52.5 | % | 55.0 | % |
| Mixed use | 11.1 | 11.7 | ||
| Retail | 8.8 | 8.4 | ||
| Multifamily | 7.3 | 7.8 | ||
| Warehouse | 6.6 | 6.5 | ||
| Office | 6.1 | 5.4 | ||
| Other (individually less than 5.0%) | 7.6 | 5.2 | ||
| Total | 100.0 | % | 100.0 | % |
As of December 31, 2024 and 2023, the Company held$68.0 million and$44.3 million, respectively, of real estate owned, net, with geographic concentrations as follows:
| December 31, | ||||
|---|---|---|---|---|
| 2024 · 2023 | ||||
| Geographic concentration: | ||||
| California | 28.6 | % | 17.5 | % |
| Texas | 17.5 | 25.9 | ||
| New York | 16.2 | 17.0 | ||
| Louisiana | 6.7 | — | ||
| Florida | 6.1 | 11.4 | ||
| Georgia | 4.0 | 5.9 | ||
| New Jersey | 2.6 | 5.8 | ||
| Other states (individually less than 5.0%) | 18.3 | 16.5 | ||
| Total | 100.0 | % | 100.0 | % |
Note 23 — Commitments and Contingencies
(a)
Repurchase Liability
When the Company sells loans, it is required to make normal and customary representations and warranties about the loans to the purchaser. The loan sale agreements generally require the Company to repurchase loans if the Company breaches a representation or warranty given to the loan purchaser. In addition, the Company may be required to repurchase loans as a result of borrower fraud or if a payment default occurs on a loan shortly after its sale.
The Company records a repurchase liability relating to representations and warranties and early payment defaults. The method used to estimate the liability for repurchase is a function of the representations and warranties given and considers a combination of factors, including, but not limited to, estimated future defaults and loan repurchase rates and the potential severity of loss in the event of defaults. The Company establishes a liability at the time loans are sold and continually update the estimated repurchase liability. The level of the repurchase liability for representations and warranties and early payment default requires considerable management judgment.
The Company regularly evaluates the adequacy of repurchase reserves based on trends in repurchase, actual loss experience, estimated future loss exposure and other relevant factors including economic conditions. As of December 31, 2024 and 2023, the balance of repurchase liability was$144 thousand and$66 thousand, respectively, and it is included in “Accounts payable and accrued expenses” in the Consolidated Balance Sheets.
(b)
The Company is a party to various legal proceedings in the normal course of business. The Company, after consultation with legal counsel, believes the disposition of all pending litigation will not have a material effect on the Company’s consolidated financial condition or results of operations.
(c)
Employee Retention Credit
Under the provisions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) signed into law on March 27, 2020 and the subsequent extension of the CARES Act, the Company, with the guidance from a third-party specialist, determined it was eligible for a refundable employee retention credit (“ERC”) subject to certain criteria.
The Company applied for ERC for the first three quarters’ wages paid in calendar year 2021. During the second quarter of 2023, the Company received approximately $4.2 million of ERC. Due to the subjectivity of the credit, the Company elected to account for the ERC as a gain analogizing to ASC 450-30, Gain Contingencies. Accordingly, the $4.2 million ERC, net of the third-party specialist fees of $0.6 million, are deferred until the uncertainty surrounding them is resolved. The net amount is included in “Accounts payable and accrued expenses” in the Consolidated Balance Sheets as of December 31, 2024 and 2023.
Note 24 — Retirement Plan
The Company maintains a qualified 401(k) retirement plan in accordance with the Internal Revenue Service code. Employees meeting certain eligibility requirements as detailed in the plan document may participate by deferring eligible compensation into the plan. The plan allows for discretionary employer matching contribution. For the years ended December 31, 2024, 2023 and 2022, the Company expensed$1.2 million,$1.0 million and$0.8 million, respectively. These amounts are included in “Compensation and employee benefits” on the Consolidated Statements of Income.
Note 25 — Other Operating Expenses
The following table presents the components of other operating expenses for the years ended December 31, 2024, 2023 and 2022:
| December 31, | ||||
|---|---|---|---|---|
| 2024 · 2023 · 2022 | ||||
| (In thousands) | ||||
| Travel, marketing and business development | $1,237 | $872 | $1,421 | |
| Data processing and telecommunications | 3,624 | 3,175 | 3,022 | |
| Office expenses | 1,265 | 1,180 | 1,160 | |
| Insurance, taxes, and licenses | 1,793 | 1,851 | 2,301 | (1) |
| Other | 1,694 | 1,446 | 1,262 | (1) |
| Total other operating expenses | $9,613 | $8,524 | $9,166 | |
(1)
Certain accounts have been reclassified to origination expenses for the year ended December 31, 2022 to conform to current period presentation.
Note 26 — Warrants and Related Party Transactions
On April 7, 2020, the Company issued and sold in a private placement 45,000 newly issued shares of Series A Convertible Preferred Stock, par value $0.01 per share (the “Preferred”), at a price per share of $1,000, plus warrants (the “Warrants”) to purchase an aggregate of 3,013,125 shares of the Company’s common stock to funds affiliated with TruArc Partners (“TruArc”), formerly Snow Phipps, and a fund affiliated with Pacific Investment Management Company LLC (“TOBI”). TruArc and TOBI are considered affiliates and, therefore, are related parties to the Company. The awards were treated as equity awards at the date of issuance.
On October 8, 2021, the Company exercised its option to convert all of its 45,000 outstanding shares of Series A Convertible Preferred Stock into 11,688,310 shares of its common stock.
The Warrants are exercisable at the warrant holder’s option at any time and from time to time, in whole or in part, until April 7, 2025 at an exercise price of $2.96 per share of common stock, with respect to 2,008,749 of the Warrants, and at an exercise price of $4.94 per share of common stock, with respect to 1,004,375 of the Warrants. The exercise price and the number of shares of common stock issuable upon exercise of the Warrants are subject to customary anti-dilution adjustments and certain issuances of common stock (or securities convertible into or exercisable for common stock) at a price (or having a conversion or exercise price) that is less than the then current exercise price. The Company is not required to affect an exercise of Warrants, if after giving effect to the issuance of common stock upon exercise of such Warrants such warrant holder together with its affiliates would beneficially own 49% or more of the Company’s outstanding common stock. The Company’s related parties have not exercised any warrants as of December 31, 2024.
In the ordinary course of business, the Company sells held for sale loans, and issues securitized debt to various financial institutions and investors through a market bidding process. As a result of this process, the Company may sell held for sale loans and/or issue securitized debt to an affiliate. The Company sold$28.7 million and$188.4 million in UPB of loans to an affiliate during the years ended December 31, 2024 and 2022, respectively. No loans were sold to any affiliate during the year ended December 31, 2023. The Company issued $5.0 million of securitized debt to an affiliate during the year ended December 31, 2024. No securitized debt was issued to any affiliate during the years ended December 31, 2023 and 2022.
Note 27 — Fair Value Measurements
Fair Value Determination
ASC Topic 820, “Fair Value Measurement,” defines fair value, establishes a framework for measuring fair value including a three-level valuation hierarchy, and requires disclosures about fair value measurements. Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date reflecting assumptions that a market participant would use when pricing an asset or liability. The hierarchy uses three levels of inputs to measure the fair value of assets and liabilities as follows:
Level 1 - Valuation is based on quoted prices for identical instruments traded in active markets.
Level 2 - Valuation is based on quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable and can be corroborated by market data.
Level 3 - Valuation is based on significant unobservable inputs for determining the fair value of assets or liabilities. These significant unobservable inputs reflect assumptions that market participants may use in pricing the assets or liabilities.
Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period in which a change in valuation technique or methodology occurs. Given the nature of some of the Company’s assets and liabilities, clearly determinable market-based valuation inputs are often not available; therefore, these assets and liabilities are valued using internal estimates. As subjectivity exists with respect to the valuation estimates used, the fair values disclosed may not equal prices that can ultimately be realized if the assets are sold or the liabilities are settled with third parties.
Below is a description of the valuation methods for the assets and liabilities recorded at fair value on either a recurring or nonrecurring basis and for estimating fair value of financial instruments not recorded at fair value for disclosure purposes. While management believes the valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the measurement date.
Cash and Cash Equivalents and Restricted Cash
Cash and restricted cash are recorded at historical cost. The carrying amount is a reasonable estimate of fair value as these instruments have short-term maturities and interest rates that approximate market, a Level 1 measurement.
Loans Held for Investment at Amortized Cost and Loans Held for Investment at Fair Value
The Company uses a third-party loan valuation specialist to estimate the fair value of its nonperforming mortgage loans, a Level 3 measurement. The significant unobservable inputs used in the fair value measurement of the Company’s nonperforming mortgage loans are interest rates, market yield requirements, the probability of default, loss given default, voluntary prepayment speed and loss timing. The Company uses a third-party loan valuation model to estimate the fair value of its performing mortgage loans, a Level 3 measurement. The significant unobservable inputs used in the fair value measurement of the Company’s performing mortgage loans are discount rate, constant prepayment rate, constant default rate, and loss severity rate. Significant changes in any of those inputs in isolation could result in a significant change to the mortgage loans’ fair value measurement.
Collateral Dependent or Loans Individually Evaluated
Nonaccrual loans held for investment are evaluated individually and are adjusted to the fair value of the collateral when the fair value of the collateral is below the carrying value of the loan. To the extent such a loan is collateral dependent, the Company determines the allowance for credit losses based on the estimated fair value of the underlying collateral. The fair value of each loan’s collateral is generally based on appraisals or broker price opinions obtained, less estimated costs to sell, a Level 3 measurement.
Loans Held for Sale, at Fair Value
The Company elected to account for certain loans originated with the intent to sell at fair value using FASB ASC Topic 825, Financial Instruments (ASC 825). The FVO loans held for sale are measured based a discounted cash flow model, or on the fair value of securities backed by similar mortgage loans, adjusted for certain factors to approximate the fair value, including the value attributable to mortgage servicing and credit risk, and current commitments to purchase loans, a Level 2 measurement. Management identified all loans to be accounted for at estimated fair value at the instrument level. Changes in fair value are reflected in income as they occur.
Real estate owned, net, is initially recorded at the property’s estimated fair value, based on appraisals or broker price opinions obtained, less estimated costs to sell at the acquisition date, a Level 3 measurement. From time to time, nonrecurring fair value adjustments are made to real estate owned, net, based on the current updated appraised value of the property, or management’s judgment and estimation of value based on recent market trends or negotiated sales prices with potential buyers.
Mortgage Servicing Rights
The Company determined the fair values based on a third-party valuation specialist using a model that calculates the present value of estimated future net servicing income, a Level 3 measurement.
Derivative Instruments
Derivative financial instruments are measured at fair value using readily observable market inputs and the overall fair value measurement is classified as Level 2.
Secured Financing, Net (“Corporate Debt”)
The Company determined the fair values estimate of the secured financing using the estimated cash flows discounted at an appropriate market rate, a Level 3 measurement.
Warehouse Repurchase Facilities, Net
Warehouse repurchase facilities are recorded at historical cost. The carrying amount is a reasonable estimate of fair value as these instruments have short-term maturities of one-year or less and interest rates that approximate market plus a spread, a Level 2 measurement.
Securitized Debt at Amortized Cost and Securitized Debt at Fair Value
The Company obtains the fair value estimates at instrument level from a third-party broker dealer based on trader input on benchmark securities. The fair values take into consideration input factors such as bond structure and collateral characteristics, and performance and pricing factors such as yield, spread, average life, prepayment speeds, default rate, and severity. The fair values are considered a Level 2 measurement. Significant changes in any of the input factors in isolation could result in a significant change to securitized debt’s fair value measurement.
Accrued Interest Receivable and Accrued Interest Payable
The carrying amounts of accrued interest receivable and accrued interest payable approximate fair value due to the short-term nature of these instruments, a Level 1 measurement.
The Company does not have any off-balance sheet financial instruments.
Receivables Due From Servicers
The carrying amounts of receivables due from servicers approximate fair value due to the short-term nature of these instruments, a Level 1 measurement.
Fair Value Disclosures
The following tables present information on assets and liabilities measured and recorded at fair value as of December 31, 2024 and 2023, by level, in the fair value hierarchy:
| Fair Value Measurements Using · Total at | ||||
|---|---|---|---|---|
| December 31, 2024 | Level 1 | Level 2 | Level 3 | Fair Value |
| (In thousands) | ||||
| Assets: | ||||
| Nonrecurring fair value measurements: | ||||
| Individually evaluated loans requiring specific allowance, net | $— | $— | $11,884 | $11,884 |
| Real estate owned, net | — | — | 68,000 | 68,000 |
| Total nonrecurring fair value measurements | — | — | 79,884 | 79,884 |
| Recurring fair value measurements: | ||||
| Loans held for investment, at fair value | — | — | 2,766,951 | 2,766,951 |
| Mortgage servicing rights | — | — | 13,712 | 13,712 |
| Total recurring fair value measurements | — | — | 2,780,663 | 2,780,663 |
| Total assets | $— | $— | $2,860,547 | $2,860,547 |
| Liabilities: | ||||
| Recurring fair value measurements: | ||||
| Securitized debt, at fair value | $— | $2,207,408 | $— | $2,207,408 |
| Total recurring fair value measurements | — | 2,207,408 | — | 2,207,408 |
| Total liabilities | $— | $2,207,408 | $— | $2,207,408 |
| Fair Value Measurements Using · Total at | ||||
|---|---|---|---|---|
| December 31, 2023 | Level 1 | Level 2 | Level 3 | Fair Value |
| (In thousands) | ||||
| Assets: | ||||
| Nonrecurring fair value measurements: | ||||
| Individually evaluated loans requiring specific allowance, net | $— | $— | $8,475 | $8,475 |
| Real estate owned, net | — | — | 44,268 | 44,268 |
| Total nonrecurring fair value measurements | — | — | 52,743 | 52,743 |
| Recurring fair value measurements: | ||||
| Loans held for sale, at fair value | — | 17,590 | — | 17,590 |
| Loans held for investment, at fair value | — | — | 1,306,072 | 1,306,072 |
| Mortgage servicing rights | — | — | 8,578 | 8,578 |
| Total recurring fair value measurements | — | 17,590 | 1,314,650 | 1,332,240 |
| Total assets | $— | $17,590 | $1,367,393 | $1,384,983 |
| Liabilities: | ||||
| Recurring fair value measurements: | ||||
| Securitized debt, at fair value | $— | $877,417 | $— | $877,417 |
| Derivative liabilities | — | 3,665 | — | 3,665 |
| Total recurring fair value measurements | — | 881,082 | — | 881,082 |
| Total liabilities | $— | $881,082 | $— | $881,082 |
The following table presents the gain (loss) recognized on assets measured on a nonrecurring basis for the years indicated:
| December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Real estate held for sale, net | $(6,121) | $(3,903) | $(363) |
| Individually evaluated loans requiring specific allowance, net | (55) | 122 | 310 |
| Total net loss | $(6,176) | $(3,781) | $(53) |
The following tables present the primary valuation techniques and unobservable inputs related to Level 3 assets as of December 31, 2024 and 2023:
| Asset Category · Fair Value · PrimaryValuationTechnique · UnobservableInput · Range · WeightedAverage (1) | ||||||||
|---|---|---|---|---|---|---|---|---|
| ($ in thousands) | ||||||||
| Nonrecurring: | ||||||||
| Individually evaluated loans requiring allowance, net | $11,884 | Market comparables | Selling costs | 8.0% | 8.0% | |||
| Real estate owned, net | 68,000 | Market comparables | Selling costs | 8.0% | 8.0% | |||
| Recurring: | ||||||||
| Loans held for investment, at fair value | $2,766,951 | Discounted cash flow | Discount rate | 8.4% | 8.4% | |||
| Prepayment rate | 0.0% to 30.0% | 9.0% | ||||||
| Default rate | 0.1% to 2.8% | 1.0% | ||||||
| Loss severity rate | 0% to 10.5% | 1.0% | ||||||
| Mortgage servicing rights | 13,712 | Discounted cash flow | Discount rate | 8.0% | 8.0% | |||
| Prepayment rate | 2.2% to 11.7% | 5.1% | ||||||
(1)
Individually evaluated loans requiring specific allowance, net is weighted by collateral value; real estate owned, net is weighted by selling price; loans held for investment at fair value and mortgage servicing rights are weighted by UPB.
| Asset Category · Fair Value · PrimaryValuationTechnique · UnobservableInput · Range · WeightedAverage (1) | ||||||||
|---|---|---|---|---|---|---|---|---|
| ($ in thousands) | ||||||||
| Nonrecurring: | ||||||||
| Individually evaluated loans requiring allowance, net | $8,475 | Market comparables | Selling costs | 8.0% | 8.0% | |||
| Real estate owned, net | 44,268 | Market comparables | Selling costs | 8.0% | 8.0% | |||
| Recurring: | ||||||||
| Loans held for investment, at fair value | $1,306,072 | Discounted cash flow | Discount rate | 9.3% | 9.3% | |||
| Prepayment rate | 0.7% to 50.0% | 5.8% | ||||||
| Default rate | 0.0% to 1.7% | 0.7% | ||||||
| Loss severity rate | 0.0% to 14.8% | 2.1% | ||||||
| Mortgage servicing rights | 8,578 | Discounted cash flow | Discount rate | 8.0% | 8.0% | |||
| Prepayment rate | 5.3% to 16.0% | 6.5% | ||||||
(1)
Individually evaluated loans requiring specific allowance, net is weighted by collateral value; real estate owned, net is weighted by selling price; loans held for investment at fair value and mortgage servicing rights are weighted by UPB.
The following is a roll-forward of loans held for investment that are measured at estimated fair value on a recurring basis for the periods indicated:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Beginning balance | $1,306,072 | $276,095 | $1,359 |
| Originations | 1,817,600 | 1,079,811 | 267,278 |
| Loans liquidated | (339,218) | (73,623) | (765) |
| Acquisition | 14,990 | — | — |
| Principal paydowns | (44,872) | (9,940) | (261) |
| Total unrealized gain included in net income | 56,565 | 47,214 | 7,436 |
| Loans transferred to held for sale | (32,515) | (25,783) | — |
| REO transfer | (13,223) | (777) | — |
| Loans repurchased | 1,552 | 13,075 | 1,048 |
| Ending balance | $2,766,951 | $1,306,072 | $276,095 |
The following is a roll-forward of loans held for sale that are measured at estimated fair value on a recurring basis for the periods indicated:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| (In thousands) | |||
| Beginning balance | $17,590 | $— | $— |
| Originations | 23,554 | 38,036 | 31,328 |
| Loans liquidated | (72,920) | (46,843) | (31,328) |
| Principal paydowns | (31) | (22) | — |
| Total unrealized gain (loss) included in net income | (708) | 636 | — |
| Loans transferred from held for investment | 32,515 | 25,783 | — |
| Ending balance | $— | $17,590 | $— |
The Company had no securitized debt measured at estimated fair value for the year ended December 31, 2022. The following is a roll-forward of securitized debt that are measured at estimated fair value on a recurring basis for the periods indicated:
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In thousands) | ||
| Beginning balance | $877,417 | $— |
| Additions | 1,590,197 | 911,875 |
| Paydowns and payoffs | (257,625) | (43,460) |
| Total unrealized (gain) loss included in net income | (2,581) | 9,002 |
| Ending balance | $2,207,408 | $877,417 |
The Company estimates the fair value of certain financial instruments on a quarterly basis. These instruments are recorded at fair value using a valuation allowance only if they are individually evaluated. As described above, these adjustments to fair value usually result from the application of lower of cost or fair value accounting or write-downs of individual assets. As of December 31, 2024 and 2023, financial assets and liabilities measured at fair value include loans held for investment at fair value, loans held for sale at fair value, mortgage servicing rights, derivative instruments, and securitized debt at fair value. Financial assets measured at the lower of cost or estimated fair value include certain individually evaluated loans held for investment and REO, which were measured using unobservable inputs, including appraisals and broker price opinions on the values of the underlying collateral. Individually evaluated loans requiring an allowance were carried at approximately$11.9 million and$8.5 million as of December 31, 2024 and 2023, respectively, net of specific allowance for credit losses of approximately$1.0 million for each of those years.
A financial instrument is cash, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from a second entity on potentially favorable terms. The methods and assumptions used in estimating the fair values of the Company’s financial instruments are described above.
The following tables present carrying amounts and estimated fair values of certain financial instruments as of the dates indicated. The estimated fair value of loans held for sale at fair value, loans held for investment at fair value, mortgage servicing rights, and securitized debt at fair value are also presented in Notes 5,6,11, and 17, respectively.
| Carrying · Estimated | |||||
|---|---|---|---|---|---|
| Asset Category | Value | Level 1 | Level 2 | Level 3 | Fair Value |
| (In thousands) | |||||
| Assets: | |||||
| Cash | $49,901 | $49,901 | $— | $— | $49,901 |
| Restricted cash | 20,929 | 20,929 | — | — | 20,929 |
| Loans held for investment, at amortized cost | 2,420,116 | — | — | 2,321,141 | 2,321,141 |
| Loans held for investment, at fair value | 2,766,951 | — | — | 2,766,951 | 2,766,951 |
| Accrued interest receivables | 35,235 | 35,235 | — | — | 35,235 |
| Mortgage servicing rights | 13,712 | — | — | 13,712 | 13,712 |
| Liabilities: | |||||
| Secured financing, net | $284,833 | $— | $— | $287,970 | $287,970 |
| Warehouse and repurchase facilities, net | 348,082 | — | 348,082 | — | 348,082 |
| Securitized debt, at amortized cost | 2,019,056 | — | 1,820,945 | — | 1,820,945 |
| Securitized debt, at fair value | 2,207,408 | — | 2,207,408 | — | 2,207,408 |
| Accrued interest payable | 28,028 | 28,028 | — | — | 28,028 |
| Carrying · Estimated | ||||||||
|---|---|---|---|---|---|---|---|---|
| Asset Category · Value · Level 1 · Level 2 · Level 3 · Fair Value | ||||||||
| (In thousands) | ||||||||
| Assets: | ||||||||
| Cash | $40,566 | $40,566 | $— | $— | $40,566 | |||
| Restricted cash | 21,361 | 21,361 | — | — | 21,361 | |||
| Loans held for sale, net | 17,590 | — | 17,590 | — | 17,590 | |||
| Loans held for investment, at amortized cost | 2,828,123 | — | — | 2,672,705 | 2,672,705 | |||
| Loans held for investment, at fair value | 1,306,072 | — | — | 1,306,072 | 1,306,072 | |||
| Accrued interest receivable | 27,028 | 27,028 | — | — | 27,028 | |||
| Mortgage servicing rights | 8,578 | — | — | 8,578 | 8,578 | |||
| Liabilities: | ||||||||
| Secured financing, net | $211,083 | $— | $— | $212,625 | $212,625 | |||
| Warehouse repurchase facilities, net | 334,755 | — | 334,755 | — | 334,755 | |||
| Securitized debt, at amortized cost | 2,418,811 | — | 2,155,718 | — | 2,155,718 | |||
| Securitized debt, at fair value | 877,417 | 877,417 | — | 877,417 | ||||
| Derivative liability | 3,665 | — | 3,665 | — | 3,665 | |||
| Accrued interest payable | 20,473 | 20,473 | — | — | 20,473 | |||
Note 28 — Select Quarterly Financial Data (Unaudited)
The following table sets forth the Company’s unaudited quarterly results for the periods indicated:
| Three Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|
| December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | |
| (In thousands) | ||||||||
| Interest income | $113,484 | $105,070 | $97,760 | $90,529 | $86,269 | $79,088 | $74,897 | $70,521 |
| Interest expense — portfolio related | 68,484 | 63,871 | 59,188 | 55,675 | 51,405 | 47,583 | 45,451 | 42,029 |
| Net interest income — portfolio related | 45,000 | 41,199 | 38,572 | 34,854 | 34,864 | 31,505 | 29,446 | 28,492 |
| Interest expense — corporate debt | 6,143 | 6,143 | 6,155 | 5,380 | 4,140 | 4,138 | 4,139 | 4,139 |
| Net interest income | 38,857 | 35,056 | 32,417 | 29,474 | 30,724 | 27,367 | 25,307 | 24,353 |
| Provision for (reversal of) credit losses | 22 | (69) | 218 | 1,002 | 827 | 154 | 298 | 636 |
| Net interest income after provision for (reversal of) credit losses | 38,835 | 35,125 | 32,199 | 28,472 | 29,897 | 27,213 | 25,009 | 23,717 |
| Other operating income (1) | 32,330 | 20,732 | 22,561 | 25,775 | 21,670 | 17,360 | 14,037 | 12,843 |
| Operating expenses (1) | 39,127 | 34,613 | 34,887 | 31,011 | 29,260 | 27,334 | 22,222 | 21,803 |
| Income before income taxes | 32,038 | 21,244 | 19,873 | 23,236 | 22,307 | 17,239 | 16,824 | 14,757 |
| Income tax expense | 11,233 | 5,627 | 5,162 | 5,903 | 5,141 | 5,070 | 4,602 | 4,021 |
| Net income | 20,805 | 15,617 | 14,711 | 17,333 | 17,166 | 12,169 | 12,222 | 10,736 |
| Net income (loss) attributable to noncontrolling interest | 218 | (186) | (67) | 82 | (189) | 83 | 39 | 87 |
| Net income attributable to Velocity Financial, Inc. | $20,587 | $15,803 | $14,778 | $17,251 | $17,355 | $12,086 | $12,183 | $10,649 |
(1)
Certain accounts included in other operating expenses prior to June 30, 2023 have been reclassified to other operating income effective June 30, 2023.
Note 29 — Segment Information
The Company operates as asingle reportable segment, conducting its business activities within the United States. The Company's chief operating decision maker (“CODM”) is its Chief Executive Officer, who reviews financial information presented on a consolidated basis.
The CODM regularly reviews net income as presented on the Company’s Consolidated Statements of Income for purposes of assessing performance and making decisions about resource allocation. Items regularly reviewed by the CODM include those line items reported on the Company’s Consolidated Statements of Income, the most significant of which include net interest income, unrealized gain (loss) on fair value loans, unrealized gain (loss) on fair value securitized debt, origination fee income, and compensation and benefits. See Consolidated Statements of Income.
Note 30 — Subsequent Events
On March 5, 2025, the Company's Board and Audit Committee approved an extension of the warrant exercise date from April 7, 2025 to May 7, 2025. The extension was approved in order to grant the holders of the warrants additional time to comply with the requirements under the Hart-Scott-Rodino anti-trust rules and regulations.
The Company has evaluated events that have occurred subsequent to December 31, 2024, and has concluded there are no other subsequent events that would require recognition in the accompanying consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.